Clinical, cellular, and molecular aspects of cancer invasion

Physiological Reviews

Volumn 83, Issue 2, 2003, Pages 337-376

  Mareel, Marc ^a   Leroy, Ancy ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; BILE ACID; CADHERIN; CATENIN; CELL SURFACE PROTEIN; CHEMOKINE; FIBROBLAST GROWTH FACTOR RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE TRIPHOSPHATASE; LEPTIN; NERVE CELL ADHESION MOLECULE; PHOSPHATASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN CDC42; PROTEIN TYROSINE KINASE; RAC PROTEIN; RAS PROTEIN; RHO FACTOR; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; THROMBIN; THROMBOCYTE ACTIVATING FACTOR; TREFOIL PEPTIDE; UVOMORULIN;

ANGIOGENESIS; APOPTOSIS; BONE METASTASIS; CANCER CELL; CANCER INVASION; CARCINOGENESIS; CELL ACTIVITY; CELL ADHESION; CELL DIFFERENTIATION; CELL GROWTH; CELL INTERACTION; CELL MIGRATION; CELL SURFACE; CELL SURVIVAL; EXTRACELLULAR MATRIX; GENE; GENE CDH1; GENE CDH2; GENE CTNNA1; GENE CTNNB1; GENE MUTATION; GENOME; MOLECULAR BIOLOGY; MOLECULAR DYNAMICS; MOLECULAR MECHANICS; MYOFIBROBLAST; OSTEOCLAST; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; REVIEW; SIGNAL TRANSDUCTION; SUPPRESSOR GENE; TUMOR ASSOCIATED LEUKOCYTE; TUMOR SUPPRESSOR GENE; VIRULENCE GENE;

EID: 0037379779     PISSN: 00319333     EISSN: None     Source Type: Journal    
DOI: 10.1152/physrev.00024.2002     Document Type: Review

References (459)

1. ABERCROMBIE M AND HEAYSMAN JEM. Invasive behavior between sarcoma and fibroblast populations in cell culture. J Natl Cancer Inst 56: 561-570, 1976.
2. ALBRECHT-BUEHLER G. The phagokinetic tracks of 3T3 cells. Cell 11: 395-404, 1977.
3. ALLAVENA P, SICA A, VECCHI A, LOCATI M, SOZZANI S, AND MANTOVANI A. The chemokine receptor switch paradigm and dendritic cell migration: its significance in tumor tissues. Immunol Rev 177: 141-149, 2000.
4. AMBARTSUMIAN NS, GRIGORIAN MS, FOSSAR LARSEN I, KARLSTRØM O, SIDENIUS N, RYGAARD J, GEORGIEV G, AND LUKANIDIN E. Metastasis of mammary carcinomas in GRS/A hybrid mice transgenic for the mts1 gene. Oncogene 13: 1621-1630, 1996.
5. ANASTASIADIS PZ, MOON SY, THORESON MA, MARINER DJ, CRAWFORD HC, ZHENG Y, AND REYNOLDS AB. Inhibition of RhoA by p120 catenin. Nature Cell Biol 2: 637-644, 2000.
6. ANDRÉ F, RIGOT V, THIMONIER J, MONTIXI C, PARAT F, POMMIER G, MARVALDI J, AND LUIS J. Integrins and E-cadherin cooperate with IGF-I to induce migration of epithelial colonic cells. Int J Cancer 83: 497-505, 1999.
7. ANDREASEN PA, KJØLLER L, CHRISTENSEN L, AND DUFFY MJ. The urokinase-type plasminogen activator system in cancer metastasis: a review. Int J Cancer 72: 1-22, 1997.
8. ANKRI S, STOLARSKY T, KOOLE L, KATZ U, AND MIRELMAN D. Antisense inhibition of expression of the light subunit (35kDa) of the Gal/GalNac lectin complex inhibits Entamoeba histolytica virulence. Mol Microbiol 33: 327-337, 1999.
9. ANKRI S, STOLARSKY T, AND MIRELMAN D. Antisense inhibition of expression of cysteine proteinases does not affect Entamoeba histolytica cytopathic or haemolytic activity but inhibits phagocytosis. Mol Microbiol 28: 777-785, 1998.
10. 1-integrins. J Cell Biol 149: 1263-1273, 2000.
11. ATTOUB S, NOË V, PIROLA L, BRUYNEEL E, CHASTRE E, MAREEL M, WYMANN MP, AND GESPACH C. Leptin promotes invasiveness of kidney and colonic epithelial cells via phosphoinositide 3-kinase-, Rho- and Rac-dependent signaling pathways. FASEB J 14: 2329-2338, 2000.
12. AVERY OT, MACLEOD CM, AND MCCARTY M. Studies on the chemical nature of the substance inducing transformation of pneumococcal types. J Exp Med 79: 137-159, 1944.
13. AZENSHTEIN E, LUBOSHITS G, SHINA S, NEUMARK E, SHAHBAZIAN D, WEIL M, WIGLER N, KEYDAR I, AND BEN-BARUCH A. The CC chemokine RANTES in breast carcinoma progression: regulation of expression and potential mechanisms of promalignant activity. Cancer Res 62: 1093-1102, 2002.
14. BAJOU K, MASSON V, GERARD RD, SCHMITT PM, ALBERT V, PRAUS M, LUND LR, FRANDSEN TL, BRUNNER N, DANO K, FUSENIG NE, WEIDLE U, CARMELIET G, LOSKUTOFF D, COLLEN D, CARMELIET P, FOIDART JM, AND NOËL A. The plasminogen activator inhibitor PAL-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin: implications for antiangiogenic strategies. J Cell Biol 152: 777-784, 2001.
15. BAJOU K, NOËL A, GERARD RD, MASSON V, BRUNNER N, HOLST-HANSEN C, SKOBE M, FUSENIG NE, CARMELIET P, COLLEN D, AND FOIDART JM. Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization. Nature Med 4: 923-928, 1998.
16. BARBIER M, ATTOUB S, CALVEZ R, LAFFARGUE M, JARRY A, MAREEL M, ALTRUDA F, GESPACH C, Wu D, LU B, HIRSCH E, AND WYMANN MP. Tumor biology. Weakening link to colorectal cancer? Nature 413: 796, 2001.
17. BARKER N AND CLEVERS H. Catenins, Wnt signaling and cancer. Bioessays 22: 961-965, 2000.
18. BARTEK J AND LUKAS J. Are all cancer genes equal? Nature 411: 1001-1002, 2001.
19. BARTH AIM, NÄTHKE IS, AND NELSON WJ. Cadherins, catenins and APC protein: interplay between cytoskeletal complexes and signaling pathways. Curr Opin Cell Biol 9: 683-690, 1997.
20. BASSET P, BELLOCQ JP, WOLF C, STOLL I, HUTIN P, LIMACHER JM, PODHAJCER OL, CHENARD MP, RIO MC, AND CHAMBON P. A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 348: 699-704, 1990.
21. BATLLE E, SANCHO E, FRANCI C, DOMINGUEZ D, MONFAR M, BAULIDA J, AND GARCIA DE HERREROS A. The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2: 84-89, 2000.
22. BATSCHÉ E AND CRÉMISI C. Opposite transcriptional activity between the wild type c-myc gene coding for c-Myc1 and c-Myc2 proteins and c-Myc1 and c-Myc2 separately. Oncogene 18: 5662-5671, 1999.
23. BATTSCHÉ E, MUCHARDT C, BEHRENS J, HURST HC, AND CRÉMISI C. RB and c-Myc activate expression of the E-cadherin gene in epithelial cells through interaction with transcription factor AP-2. Mol Cell Biol 18: 3647-3658, 1998.
24. BAUER A, CHAUVET S, HUBER O, USSEGLIO F, ROTHBÄCHER U, ARAGNOL D, KEMLER R, AND PRADEL J. Pontin52 and Reptin52 function as antagonistic regulators of β-catenin signalling activity. EMBO J 19: 6121-6130, 2000.
25. BECKER KF, ATKINSON MJ, REICH U, BECKER I, NEKARDA H, SIEWERT JR, AND HÖFLER H. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res 54: 3845-3852, 1994.
26. BECKER KF, ATKINSON MJ, REICH U, HUANG HH, NEKARDA H, SIEWERT JR, AND HÖFLER H. Exon skipping in the E-cadherin gene transcript in metastatic human gastric carcinomas. Hum Mol Genet 2: 803-804, 1993.
27. BECKER KF, KELLER G, AND HOEFLER H. The use of molecular biology in diagnosis and prognosis of gastric cancer. Surg Oncol 9: 5-11, 2000.
28. BEHRENS J. Control of β-catenin signaling in tumor development. Ann NY Acad Sci 910: 21-35, 2000.
29. BEHRENS J, LÖWRICK O, KLEIN-HITPASS L, AND BIRCHMEIER W. The E-cadherin promoter: functional analysis of a GC-rich region and an epithelial cell-specific palindromic regulatory element. Proc Natl Acad Sci USA 88: 11495-11499, 1991.
30. BEHRENS J, MAREEL MM, VAN ROY FM, AND BIRCHMEIER W. Dissecting tumor cell invasion: epithelial cells acquire invasive properties following the loss of uvomorulin-mediated cell-cell adhesion. J Cell Biol 108: 2435-2447, 1989.
31. BEHRENS J, VAKAET L, FRIIS R, WINTERHAGER E, VAN ROY F, MAREEL MM, AND BIRCHMEIER W. Loss of epithelial morphotype and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/β-catenin complex in cells transformed with a temperature-sensitive v-src gene. J Cell Biol 120: 757-766, 1993.
32. BEHRENS J, VON KRIES JP, KÜHL M, BRUHN L, WEDLICH D, GROSSCHEDL R, AND BIRCHMEIER W. Functional interaction of β-catenin with the transcription factor LEF-1. Nature 382: 638-642, 1996.
33. BELLUSCI S, MOENS G, GAUDINO G, COMOGLIO P, NAKAMURA T, THIERY JP, AND JOUANNEAU J. Creation of an hepatocyte growth factor/scatter factor autocrine loop in carcinoma cells induces invasive properties associated with increased tumorigenicity. Oncogene 9: 1091-1099, 1994.
34. BERGERS G AND COUSSENS LM. Extrinsic regulators of epithelial tumor progression: metalloproteinases. Curr Opin Genet Dev 10: 120-127, 2000.
35. BERX G, BECKER KF, HÖFLER H, AND VAN ROY F. Mutations of the human E-cadherin (CDH1) gene. Hum Murat 12: 226-237, 1998.
36. BERX G, CLETON-JANSEN AM, NOLLET F, DE LEEUW WJF, VAN DE VIJVER MJ, CORNELISSE C, AND VAN ROY F. E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. EMBO J 14: 6107-6115, 1995.
37. BEVIGLIA L AND KRAMER RH. HGF induces FAK activation and integrin-mediated adhesion in MTLn3 breast carcinoma cells. Int J Cancer 83: 640-649, 1999.
38. BHOWMICK NA, GHIASSI M, BAKIN A, AAKRE M, LUNDQUIST CA, ENGEL ME, ARTEAGA CL, AND MOSES HL. Transforming growth factor-β1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol Biol Cell 12: 27-36, 2001.
39. BIRCHMEIER C, SONNENBERG E, WEIDNER IM, AND WALTER B. Tyrosine kinase receptors in the control of epithelial growth and morphogenesis during development. Bioessays 15: 185-190, 1993.
40. BISHOP JM. Molecular themes in oncogenesis. Cell 64: 235-248, 1991.
41. BJØRBEK C, UOTANI S, DA SILVA B, AND FLIER JS. Divergent signaling capacities of the long and short isoforms of the leptin receptor. J Biol Chem 272: 32686-32695, 1997.
42. BLUME-JENSEN P AND HUNTER T. Oncogenic kinase signalling. Nature 411: 355-365, 2001.
43. BONDEVA T, PIROLA L, BULGARELLI-LEVA G, RUBIO I, WETZKER R, AND WYMANN MP. Bifurcation of lipid and protein kinase signals of PI3Kγ to the protein kinases PKB and MAPK. Science 282: 293-296, 1998.
44. BONVINI P, AN WG, ROSOLEN A, NGUYEN P, TREPEL J, GARCIA DE HERREROS A, DUNACH M, AND NECKERS LM. Geldanamycin abrogates ErbB2 association with proteasome-resistant β-catenin in melanoma cells, increases β-catenin-E-cadherin association, and decreases β-catenin-sensitive transcription. Cancer Res 61: 1671-1677, 2001.
45. Bos JL. ras Oncogenes in human cancer: a review. Cancer Res 49: 4682-4689, 1989.
46. BOTERBERG T, BRACKE ME, BRUYNEEL EA, AND MAREEL MM. Cell aggregation assays. In: Methods in Molecular Medicine. Metastasis Research Protocols. Cell Behavior In Vitro and In Vivo, edited by Brooks SA and Schumacher U. Totowa, NJ: Humana, 2001, vol. 58, pt. 2, p. 33-45.
47. BOTERBERG T, VENNEKENS KM, THIENPONT M, MAREEL MM, AND BRACKE ME. Internalization of the E-cadherin/catenin complex and scattering of human mammary carcinoma cells MCF-7/AZ after treatment with conditioned medium from human skin squamous carcinoma cells COLO 16. Cell Adhesion Commun 7: 299-310, 2000.
48. BOTTARO DP, RUBIN JS, FALETTO DL, CHAN AML, KMIECIK TE, VANDE WOUDE GF, AND AARONSON SA. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 251: 802-804, 1991.
49. BOUDREAU N AND BISSELL MJ. Extracellular matrix signaling: integration of form and function in normal and malignant cells. Curr Opin Cell Biol 10: 640-646, 1998.
50. BOULAY A, MASSON R, CHENARD MP, EL FAHIME M, CASSARD L, BELLOCQ JP, SAUTÈS-FRIDMAN C, BASSET P, AND RIO MC. High cancer cell death in syngeneic tumors developed in host mice deficient for the stromelysin-3 matrix metalloproteinase. Cancer Res 61: 2189-2193, 2001.
51. BOYER B, BOURGEOIS Y, AND POUPON MF. Src kinase contributes to the metastatic spread of carcinoma cells. Oncogene 21: 2347-2356, 2002.
52. BRABANT G, HOANG-VU C, BEHRENDS J, CETIN Y, PÖTTER E, DUMONT JE, AND MAENHAUT C. Regulation of the cell-cell adhesion protein, E-cadherin, in dog and human thyrocytes in vitro. Endocrinology 136: 3113-3119, 1995.
53. BRABLETZ T, JUNG A, REU S, PORZNER M, HLUBEK F, KUNZ-SCHUGHART LA, KNUECHEL R, AND KIRCHNER T. Variable β-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proc Natl Acad Sci USA 98: 10356-10361, 2001.
54. BRACHA R, NUCHAMOWlTZ Y, LEIPPE M, AND MIRELMAN D. Antisense inhibition of amoebapore expression in Entamoeba histolytica causes a decrease in amoebic virulence. Mol Microbiol 34: 463-472, 1999.
55. BRACKE ME, DEPYPERE H, LABIT C, VAN MARCK V, VENNEKENS K, VERMEULEN SJ, MAELFAIT I, PHILIPPÉ J, SERREYN R, AND MAREEL MM. Functional downregulation of the E-cadherin/catenin complex leads to loss of contact inhibition of motility and of mitochondrial activity, but not of growth in confluent epithelial cell cultures. Eur J Cell Biol 74: 342-349, 1997.
56. BRACKE ME, VAN ROY FM, AND MAREEL MM. The E-cadherin/catenin complex in invasion and metastasis. In: Attempts to Understand Metastasis Formation I, edited by Günthert U and Birchmeier W. Berlin: Springer, 1996, p. 123-161.
57. BRAMBILLA E, GAZZERI S, LANTUEJOUL S, COLL JL, MORO D, NEGOESCU A, AND BRAIMBILLA C. p53 Mutant immunophenotype and deregulation of p53 transcription pathway (Bcl2, Bax, and Waf1) in precursor bronchial lesions of lung cancer. Clin Cancer Res 4: 1609-1618, 1998.
58. BRANCOLINI C, LAZAREVIC D, RODRIGUEZ J, AND SCHNEIDER C. Dismantling cell-cell contacts during apoptosis is coupled to a caspase-dependent proteolytic cleavage of β-catenin. J Cell Biol 139: 759-771, 1997.
59. BRAUN L, GHEBREHIWET B, AND COSSART P. gC1q-R/p32, a C1q-binding protein, is a receptor for the InIB invasion protein of Listeria monocytogenes. EMBO J 19: 1458-1466, 2000.
60. BRIEHER WM, YAP AS, AND GUMBINER BM. Lateral dimerization is required for the homophilic binding activity of C-cadherin. J Cell Biol 135: 487-496, 1996.
61. BROOKS SA AND SCHUMACHER U. (Editors). Methods in Molecular Medicine. Metastasis Research Protocols. Cell Behavior In Vitro and In Vivo. Totowa, NJ: Humana, 2001, vo. 58, pt. 2.
62. BROWN EL, WOOTEN RM, JOHNSON BJB, IOZZO RV, SMITH A, DOLAN MC, GUO BP, WEIS JJ, AND HÖÖK M. Resistance to Lyme disease in decorin-deficient mice. J Clin Invest 107: 845-852, 2001.
63. BUKHOLM IK, NESLAND JM, AND BØRRESEN-DALE AL. Re-expression of E-cadherin, α-catenin and β-catenin, but not of γ-catenin, in metastatic tissue from breast cancer patients. J Pathol 190: 15-19, 2000.
64. BURKE JM, CAO F, IRVING PE, AND SKUMATZ CMB. Expression of E-cadherin by human retinal pigment epithelium: delayed expression in vitro. Invest Ophthalmol Vis Sci 40: 2963-2970, 1999.
65. CAIRNS P, EVRON E, OKAMI K, HALACHMI N, ESTELLER M, HERMAN JG, BOSE S, WANG SI, PARSONS R, AND SIDRANSKY D. Point mutation and homozygous deletion of PTEN/MMAC1 in primary bladder cancers. Oncogene 16: 3215-3218, 1998.
66. CAIRNS P, OKAMI K, HALACHMI S, HALACHMI N, ESTELLER M, HERMAN JG, JEN J, ISAACS WB, BOVA GS, AND SIDRANSKY D. Frequent inactivation of PTEN/MMAC1 in primary prostate cancer. Cancer Res 57: 4997-5000, 1997.
67. CANDIDUS S, BISCHOFF P, BECKER KF, AND HÖFLER H. No evidence for mutations in the α- and β-catenin genes in human gastric and breast carcinomas. Cancer Res 56: 49-52, 1996.
68. CANO A, PÉREZ-MORENO MA, RODRIGO I, LOCASCIO A, BLANCO MJ, DEL BARRIO MG, PORTILLO F, AND NIETO MA. The transcription factor Snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nature Cell Biol 2: 76-83, 2000.
69. CANTLEY LC AND NEEL BG. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc Natl Acad Sci USA 96: 4240-4245, 1999.
70. CARMELIET P. Mechanisms of angiogenesis and arteriogenesis. Nature Med 6: 389-395, 2000.
71. CARTER RL. (Editor). Precancerous States. New York: Oxford Univ. Press, 1984.
72. CARTWRIGHT CA, COAD CA, AND EGBERT BM. Elevated c-Src tyrosine kinase activity in premalignant epithelia of ulcerative colitis. J Clin Invest 93: 509-515, 1994.
73. CAVALLARO U, NIEDERMEYER J, FUXA M, AND CHRISTOFORI G. N-CAM modulates tumour-cell adhesion to matrix by inducing FGF-receptor signalling. Nat Cell Biol 3: 650-657, 2001.
74. 7 integrin. Nature 372: 190-193, 1994.
75. CHASTRE E, EMPEREUR S, DI GIOIA Y, EL MAHDANI N, MAREEL M, VLEMINCKX K, VAN ROY F, BEX V, EMAMI S, SPANDIDOS DA, AND GESPACH C. Neoplastic progression of human and rat intestinal cell lines after transfer of the ras and polyoma middle T oncogenes. Gastroenterology 105: 1776-1789, 1993.
76. CHAUSOVSKY A, BERSHADSKY AD, AND BORISY GG. Cadherin-mediated regulation of microtubule dynamics. Nature Cell Biol 2: 797-804, 2000.
77. CHEN JJW, PECK K, HONG TM, YANG SC, SHER YP, SHIH JY, WU R, CHENG JL, ROFFLER SR, WU CW, AND YAN6 PC. Global analysis of gene expression in invasion by a lung cancer model. Cancer Res 61: 5223-5230, 2001.
78. CHEN WT AND WANG JY. Specialized surface protrusions of invasive cells, invadopodia and lamellipodia, have differential MT1-MMP, MMP-2, and TIMP-2 localization. Ann NY Acad Sci 30: 361-371, 1999.
79. COLLARD JG. Signaling pathways regulated by Rho-like proteins: a possible role in tumor formation and metastasis (review). Int J Oncol 8: 131-138, 1996.
80. COMAN DR. Decreased mutual adhesiveness, a property of cells from squamous cell carcinomas. Cancer Res 4: 625-629, 1944.
81. COMIJN J, BERX G, VERMASSEN P, VERSCHUEREN K, VAN GRUNSVEN L, BRUYNEEL E, MAREEL M, HUYLEBROECK D, AND VAN ROY F. The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell 7: 1267-1278, 2001.
82. COMOGLIO PM. Pathway specificity for Met signalling. Nat Cell Biol 3: E161-E162, 2001.
83. COOPMAN PJ, BRACKE ME, LISSITZKY JC, DE BRUYNE GK, VAN ROY FM, FOIDART JM, AND MAREEL MM. Influence of basement membrane molecules on directional migration of human breast cell lines in vitro. J Cell Sci 98: 395-401, 1991.
84. COOPMAN PJ, THOMAS DM, GEHLSEN KR, AND MUELLER SC. Integrin α3β1 participates in the phagocytosis of extracellular matrix molecules by human breast cancer cells. Mol Biol Cell 7: 1789-1804, 1996.
85. 7. J Biol Chem 276: 30862-30870, 2001.
86. COSSART P. Actin-based motility of pathogens: the Arp2/3 complex is a central player. Cell Microbiol 2: 195-205, 2000.
87. COSSART P. Met, the HGF-SF receptor: another receptor for Listeria monocytogenes. Trends Microbiol 9: 105-107, 2001.
88. COSSART P AND BIERNE H. The use of host cell machinery in the pathogenesis of Listeria monocytogenes. Curr Opin Immunol 13: 96-103, 2001.
89. COUGHLIN SR. Thrombin signalling and protease-activated receptors. Nature 407: 258-264, 2000.
90. CRAWFORD HC, FINGLETON BM, RUDOLPH-OWEN LA, HEPPNER GOSS KJ, RUBINFELD B, POLAKIS P, AND MATRISIAN LM. The metalloproteinase matrilysin is a target of β-catenin transactivation in intestinal tumors. Oncogene 18: 2883-2891, 1999.
91. DAHL U, SJÖDIN A, AND SEMB H. Cadherins regulate aggregation of pancreatic β-cells in vivo. Development 122: 2895-2902, 1996.
92. DANEN EHJ, DE VRIES TJ, MORANDINI R, GHANEM GG, RUITER DJ, AND VAN MUIJEN GNP. E-cadherin expression in human melanoma. Melanoma Res 6: 127-131, 1996.
93. DANIEL JM AND REYNOLDS AB. Tyrosine phosphorylation and cadherin/catenin function. Bioessays 19: 883-891, 1997.
94. ctn interacts with Kaiso, a novel BTB/POZ domain zinc finger transcription factor. Mol Cell Biol 19: 3614-3623, 1999.
95. DAVIES EL, GEE JMW, COCHRANE RA, JIANG WG, SHARMA AK, NICHOLSON RI, AND MANSEL RE. The immunohistochemical expression of desmoplakin and its role in vivo in the progression and metastasis of breast cancer. Eur J Cancer 35: 902-907, 1999.
96. DE BAETSELIER P, ROOS E, BRYS L, REMELS L, GOBERT M, DEKEGEL D, SEGAL S, AND FELDMAN M. Nonmetastatic tumor cells acquire metastatic properties following somatic hybridization with normal cells. Cancer Metastasis Rev 3: 5-24, 1984.
97. DEBRUYNE PR, BRUYNEEL EA, LI X, ZIMBER A, GESPACH C, AND MAREEL MM. The role of bile acids in carcinogenesis. Mutat Res 480-481: 359-369, 2001.
98. DEBRUYNE P, VERMEULEN S, AND MAREEL M. The role of the E-cadherin/catenin complex in gastrointestinal cancer. Acta Gastroenterol Belg LXII: 393-403, 1999.
99. DE CASTRO J, GAMALLO C, PALACIOS J, MORENO-BUENO G, RODRÍGUEZ N, FELIU J, AND GONZÁLEZ-BARÓN M. β-Catenin expression pattern in primary oesophageal squamous cell carcinoma. Relationship with clinicopathologic features and clinical outcome. Virchows Arch 437: 599-604, 2000.
100. DE MARZO AM, MARCHI VL, EPSTEIN JI, AND NELSON WG. Proliferative inflammatory atrophy of the prostate. Implications for prostatic carcinogenesis. Am J Pathol 155: 1985-1992, 1999.
101. DENG G, LU Y, ZLOTNIKOV G, THOR AD, AND SMITH HS. Loss of heterozygosity in normal tissue adjacent to breast carcinomas. Science 274: 2057-2059, 1996.
102. DE RIDDER L, MAREEL M, AND VAKAET L. Adhesion of malignant and nonmalignant cells to cultured embryonic substrates. Cancer Res 35: 3164-3171, 1975.
103. DÉRY O, CORVERA CU, STEINHOFF M, AND BUNNETT NW. Proteinase-activated receptors: novel mechanisms of signaling by serine proteases. Am J Physiol Cell Physiol 274: C1429-C1452, 1998.
104. DERYNCK R, ZHANG Y, AND FENG XH. Smads: transcriptional activators of TGF-β responses. Cell 95: 737-740, 1998.
105. DEVITA VT JR, HELLMAN S, AND ROSENBERG SA. (Editors). Cancer. Principles and Practice of Oncology (5th ed.). Philadelphia, PA; Lippincott-Raven, 1997.
106. DE WEVER O AND MAREEL M. Role of myofibroblasts at the invasion front. J Biol Chem 383: 55-67, 2002.
107. DI CRISTOFANO A AND PANDOLFI PP. The multiple roles of PTEN in tumor suppression. Cell 100: 387-390, 2000.
108. DIMANCHE-BOITREL MT, VAKAET L JR, PUJUGUET P, CHAUFFERT B, MARTIN MS, HAMMANN A, VAN ROY F, MAREEL M, AND MARTIN F. In vivo and in vitro invasiveness of a rat colon cancer cell line maintaining E-cadherin expression. An enhancing role of tumor-associated myofibroblasts. Int J Cancer 56: 512-521, 1994.
109. DINGEMANS KP. Behavior of intravenously injected malignant lymphoma cells. A morphologic study. J Natl Cancer Inst 51: 1883-1895, 1973.
110. DI RENZO MF, OLIVERO M, FERRO S, PRAT M, BONGARZONE I, PILOTTI S, BELFIORE A, COSTANTINO A, VIGNERI R, PIEROTI MA, AND COMOGLIO PM. Overexpression of the c-MET/HGF receptor gene in human thyroid carcinomas. Oncogene 7: 2549-2553, 1992.
111. DI RENZO MF, OLIVERO M, GIACOMINI A, PORTE H, CHASTRE E, MIROSSAY L, NORDLINGER B, BRETTI S, BOTTARDI S, GIORDANO S, PLEBANI M, GESPACH C, AND COMOGLIO PM. Overexpression and amplification of the Met/HGF receptor gene during the progression of colorectal cancer. Clin Cancer Res 1: 147-154, 1995.
112. DOHERTY P AND WALSH FS. CAM-FGF receptor interactions: a model for axonal growth. Mol Cell Neurosci 8: 99-111, 1996.
113. DOWNWARD J. The ins and outs of signalling. Nature 411: 759-762, 2001.
114. DUERR EM, ROLLBROCKER B, HAYASHI Y, PETERS N, MEYER-PUTTLITZ B, LOUIS DN, SCHRAMM J, WIESTLER OD, PARSONS R, ENG C, AND VON DEIMLING A. PTEN mutations in gliomas and glioneuronal tumors. Oncogene 16: 2259-2264, 1998.
115. DVORAK HF. Tumors: wounds that do not heal. N Engl J Med 315: 1650-1659, 1986.
116. EADS CA, LORD RV, KURUMBOOR SK, WICKRAMASINGHE K, SKINNER ML, LONG TI, PETERS JH, DEMEESTER TR, DANENBERG KD, DANENBERG PV, LAIRD PW, AND SKINNER KA. Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma. Cancer Res 60: 5021-5026, 2000.
117. EASTY GC AND EASTY DM. An organ culture system for the examination of tumour invasion. Nature 199: 1104-1105, 1963.
118. EDELMAN GM, GALLIN WJ, DELOUVEE A, CUNNINGHAM BA, AND THIERY JP. Early epochal maps of two different cell adhesion molecules. Proc Natl Acad Sci USA 80: 4384-4388, 1983.
119. EFSTATHIOU JA, NODA M, ROWAN A, DIXON C, CHINERY R, JAWHARI A, HATTORI T, WRIGHT NA, BODMER WF, AND PIGNATELLI M. Intestinal trefoil factor controls the expression of the adenomatous polyposis coli-catenin and the E-cadherin-catenin complexes in human colon carcinoma cells. Proc Natl Acad Sci USA 95: 3122-3127, 1998.
120. EGEBLAD M AND WERB Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2: 161-174, 2002.
121. ELLENRIEDER V, HENDLER SF, BOECK W, SEUFFERLEIN T, MENKE A, RUHLAND C, ADLER G, AND GRESS TM. Transforming growth factor β1 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation. Cancer Res 61: 4222-4228, 2001.
122. EMAMI S, LE FLOCH N, BRUYNEEL E, THIM L, MAY F, WESTLEY B, RIO MC, MAREEL M, AND GESPACH C. Induction of scattering and cellular invasion by trefoil peptides in src- and RhoA-transformed kidney and colonic epithelial cells. FASEB J 15: 351-361, 2001.
123. EMPEREUR S, DJELLOUL S, DI GIOIA Y, BRUYNEEL E, MAREEL M, VAN HENGEL J, VAN ROY F, COMOGLIO P, COURTNEIDGE S, PARASKEVA C, CHASTRE E, AND GESPACH C. Progression of familial adenomatous polyposis (FAP) colonic cells after transfer of the src or polyoma middle T oncogenes: cooperation between src and HGF/Met in invasion. Br J Cancer 75: 241-250, 1997.
124. ESTELLER M. Epigenetic lesions causing genetic lesions in human cancer: promoter hypermethylation of DNA repair genes. Eur J Cancer 36: 2294-2300, 2000.
125. EVAN GI AND VOUSDEN KH. Proliferation, cell cycle and apoptosis in cancer. Nature 411: 342-348, 2001.
126. EVEN-RAM S, UZIELY B, COHEN P, GRISARU-GRANOVSKY S, MAOZ M, GINZBURG Y, REICH R, VLODAVSKY I, AND BAR-SHAVIT R. Thrombin receptor overexpression in malignant and physiological invasion processes. Nature Med 4: 909-914, 1998.
127. EWING CM, RU N, MORTON RA, ROBINSON JC, WHEELOCK MJ, JOHNSON KR, BARRETT JC, AND ISAACS WB. Chromosome 5 suppresses tumorigenicity of PC3 prostate cancer cells: correlation with re-expression of α-catenin and restoration of E-cadherin function. Cancer Res 55: 4813-4817, 1995.
128. FAIVRE S, RÉGNAULD K, BRUYNEEL E, NGUYEN QD, MAREEL M, EMAMI S, AND GESPACH C. Suppression of cellular invasion by activated G-protein subunits Gαo, Gαi1, Gαi2 and Gαi3 and sequestration of Gβγ. Mol Pharmacol 60: 363-372, 2001.
129. FEARON ER. BRCA1 and E-cadherin promoter hypermethylation and gene inactivation in cancer: association or mechanism? J Natl Cancer Inst 92: 515-517, 2000.
130. FEARON ER AND VOGELSTEIN B. A genetic model for colorectal tumorigenesis. Cell 61: 759-767, 1990.
131. FENG S, WANG F, MATSUBARA A, KAN M, AND MCKEEHAN WL. Fibroblast growth factor receptor 2 limits and receptor 1 accelerates tumorigenicity of prostate epithelial cells. Cancer Res 57: 5369-5378, 1997.
132. FISHELSON Z, AMIRI P, FRIEND DS, MARIKOVSKY M, PETIT M, NEWPORT G, AND MCKERROW JH. Schistosoma mansoni: cell-specific expression and secretion of a serine protease during development of cercariae. Exp Parasitol 75: 87-98, 1992.
133. FODDE R, EDELMANN W, YANG K, VAN LEEUWEN C, CARLSON C, RENAULT B, BREUKEL C, ALT E, LIPKIN M, MEERA KHAN P, AND KUCHERLAPATI R. A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors. Proc Natl Acad Sci USA 91: 8969-8973, 1994.
134. FOLKMAN J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med 1: 27-31, 1995.
135. FOULDS L. Neoplastic Development I. New York: Academic, 1969.
136. FRIEDMAN JM AND HALAAS JL. Leptin and the regulation of body weight in mammals. Nature 395: 763-770, 1998.
137. FRISCH SM, VUORI K, RUOSLAHTI E, AND CHAN-HUI PY. Control of adhesion-dependent cell survival by focal adhesion kinase. J Cell Biol 134: 793-799, 1996.
138. FRIXEN UH, BEHRENS J, SACHS M, EBERLE G, VOSS B, WARDA A, LÖCHNER D, AND BIRCHMEIER W. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 113: 173-185, 1991.
139. FURMAN MI, LIU L, BENOIT SE, BECKER RC, BARNARD MR, AND MICHELSON AD. The cleaved peptide of the thrombin receptor is a strong platelet agonist. Proc Natl Acad Sci USA 95: 3082-3087, 1998.
140. GABBIANI G, RYAN GB, AND MAJNO G. Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction. Experientia 27: 549-550, 1971.
141. GAILLARD JL, BERCHE P, FREHEL C, GOUIN E, AND COSSART P. Entry of L. monocytogenes into cells is mediated by internalin, a repeat protein reminiscent of surface antigens from gram-positive cocci. Cell 65: 1127-1141, 1991.
142. GAO J AND ISAACS JT. Development of an androgen receptor-null model for identifying the initiation site for androgen stimulation of proliferation and suppression of programmed (apoptotic) death of PC-82 human prostate cancer cells. Cancer Res. 58: 3299-3306, 1998.
143. GENDA T, SAKAMOTO M, ICHIDA T, ASAKURA H, AND HIROHASHI S. Loss of cell-cell contact is induced by integrin-mediated cell-substratum adhesion in highly-motile and highly-metastatic hepatocellular carcinoma cells. Lab Invest 80: 387-394, 2000.
144. GERBER B, KRAUSE A, MÜLLER H, RICHTER D, REIMER T, MAKOVITZKY J, HERRNRING C, JESCHKE U, KUNDT G, AND FRIESE K. Simultaneous immunohistochemical detection of tumor cells in lymph nodes and bone marrow aspirates in breast cancer and its correlation with other prognostic factors. J Clin Oncol 19: 960-971, 2001.
145. GHERARDI E AND STOKER M. Hepatocyte growth factor-scatter factor: mitogen, motogen, and met. Cancer Cells 3: 227-232, 1991.
146. GIANCOTI FG AND RUOSLAHTI E. Integrin signaling. Science 285: 1028-1032, 1999.
147. GIANNINI AL, VIVACO M, AND KYPTA RM. α-Catenin inhibits β-catenin signaling by preventing formation of a β-catenin•T-cell factor•DNA complex. J Biol Chem 275: 21883-21888, 2000.
148. GILCHRIST CA AND PETRI WA JR. Virulence factors of Entamoeba histolytica. Curr Opin Microbiol 2: 433-437, 1999.
149. GIRARDI M, OPPENSEIM DE, STEELE CR, LEWIS JM, GLUSAC E, FILLER R, HOBBY P, SUTTON B, TIGELAAR RE, AND HAYDAY AC. Regulation of cutaneous malignancy by γδ T cells. Science 294: 605-609, 2001.
150. GIROLDI LA, BRINGUIER PP, DE WEIJERT M, JANSEN C, VAN BOKHOVEN A, AND SCHALKEN JA. Role of E boxes in the repression of E-cadherin expression. Biochem Biophys Res Commun 18: 453-458, 1997.
151. GLINGHAMMAR B AND RAFTER J. Colonic luminal contents induce cyclooxygenase 2 transcription in human colon carcinoma cells. Gastroenterology 120: 401-410, 2001.
152. GLINSKY VV, GLINSKY GV, RITTENHOUSE-OLSON K, HUFLEJT ME, GLINSKII OV, DEUTSCHER SL, AND QUINN TP. The role of Thomsen-Friedenreich antigen in adhesion of human breast and prostate cancer cells to the endothelium. Cancer Res 61: 4851-4857, 2001.
153. GONZÁLEZ MV, PELLO MF, ABLANEDO P, SUÁREZ C, ALVAREZ V, AND COTO E. Chromosome 3p loss of heterozygosity and mutation analysis of the FHIT and β-cat genes in squamous cell carcinoma of the head and neck. J Clin Pathol 51: 520-524, 1998.
154. GOTZMANN J, HUBER H, THALLINGER C, WOLSCHEK M, JANSEN B, SCHULTE-HERMANN R, BEUG H, AND MIKULITS W. Hepatocytes convert to a fibroblastoid phenotype through the cooperation of TGF-beta1 and Ha-Ras: steps towards invasiveness. J Cell Sci 115: 1189-1202, 2002.
155. GRADY WM, WILLIS J, GUILFORD PJ, DUNBIER AK, TORO TT, LYNCH H, WIESNER G, FERGUSON K, ENG C, PARK JG, KIM SJ, AND MARKOWITZ S. Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer. Nat Genet 26: 16-17, 2000.
156. GRAEBER SHM AND HÜLSER DF. Connexin transfection induces invasive properties in HeLa cells. Exp Cell Res 243: 142-149, 1998.
157. GRAHAM TA, WEAVER C, MAO F, KIMELMAN D, AND XU W. Crystal structure of a β-catenin/Tcf complex. Cell 103: 885-896, 2000.
158. GUMBINER BM. Epithelial morphogenesis. Cell 69: 385-387, 1992.
159. Guo BP, BROWN EL, DORWARD DW, ROSENBERG LC, AND HOOK M. Decorin-binding adhesins from Borrelia burgdorferi. Mol Microbiol 30: 711-723, 1998.
160. HAKIMELAHI S, PARKER HR, GILCHRIST AJ, BARRY M, Li Z, BLEACKLEY RC, AND PASDAR M. Plakoglobin regulates the expression of the anti-apoptotic protein BCL-2. J Biol Chem 275: 10905-10911, 2000.
161. HALVORSEN B, STAFF AC, LIGAARDEN S, PRYDZ K, AND KOLSET SO. Lithocholic acid and sulphated lithocholic acid differ in the ability to promote matrix metalloproteinase secretion in the human colon cancer cell line Caco-2. Biochem J 349: 189-193, 2000.
162. HAMEETEMAN W, TYTGAT GNJ, HOUTHOFF HJ, AND VAN DEN TWEEL JG. Barrett's esophagus: development of dysplasia and adenocarcinoma. Gastroenterology 96: 1249-1256, 1989.
163. HANDSCHUH G, CANDIDUS S, LUBER B, REICH U, SCHOTT C, OSWALD S, BECKE H, HUTZLER P, BIRCHMEIER W, HÖFLER H, AND BECKER KF. Tumour-associated E-cadherin mutations alter cellular morphology, decrease cellular adhesion and increase cellular motility. Oncogene 18: 4301-4312, 1999.
164. HART IR AND FIDLER IJ. An in vitro quantitative assay for tumor cell invasion. Cancer Res 38: 3218-3224, 1978.
165. HATTA K AND TAKEICHI M. Expression of N-Cadherin adhesion molecules associated with early morphogenetic events in chick development. Nature 320: 447-449, 1986.
166. HAZAN RB, KANG L, WHOOLEY BP, AND BORGEN PI. N-cadherin promotes adhesion between invasive breast cancer cells and the stroma. Cell Adhesion Commun 4: 399-411, 1997.
167. HAZAN RB, PHILLIPS GR, FANG QIAO R, NORTON L, AND AARONSON SA. Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J Cell Biol 148: 779-790, 2000.
168. HE TC, SPARKS AB, RAGO C, HERMEKING H, ZAWEL L, DA COSTA LT, MORIN PJ, VOGELSTEIN B, AND KINZLER KW. Identification of c-MYC as a target of the APC pathway. Science 281: 1509-1512, 1998.
169. HECHT A, VLEMINCKX K, STEMMLER MP, VAN ROY F, AND KEMLER R. The p300/CBP acetyltransferases function as transcriptional coactivators of β-catenin in vertebrates. EMBO J 19: 1839-1850, 2000.
170. HIGASHI H, TSUTSUMI R, MUTO S, SUGIYAMA T, AZUMA T, ASAKA M, AND HATAKEYAMA M. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science 295: 683-686, 2002.
171. HILKENS J, LIGTENSERG MJL, VOS HL, AND LITVINOV SV. Cell membrane-associated mucins and their adhesion-modulating property. Trends Biochem Sci 17: 359-363, 1992.
172. HIRAGA T, WILLIAMS PJ, MUNDY GR, AND YONEDA T. The biphosphonate ibandronate promotes apoptosis in MDA-MB-231 human breast cancer cells in bone metastases. Cancer Res 61: 4418-4424, 2001.
173. HIRANO S AND TAKEICHI M. Differential expression of αN-catenin and N-cadherin during early development of chicken embryos. Int J Dev Biol 38: 379-384, 1994.
174. HOSONO S, GROSS I, ENGLISH MA, HAJRA KM, FEARON ER, AND LICHT JD. E-cadherin is a WT1 target gene. J Biol Chem 275:10943-10953, 2000.
175. Hsu MY, WHEELOCK MJ, JOHNSON KR, AND HERLYN M. Shifts in cadherin profiles between human normal melanocytes and melanomas. J Invest Dermatol Symp Proc 1: 188-194, 1996.
176. HUBER AH, STEWART DB, LAURENTS DV, NELSON WJ, AND WEISS WI. The cadherin cytoplasmic domain is unstructured in the absence of β-catenin. A possible mechanism for regulating cadherin turnover. J Biol Chem 276: 12301-12309, 2001.
177. HUBER O, KEMLER R, AND LANGOSCH D. Mutations affecting transmembrane segment interactions impair adhesiveness of E-cadherin. J Cell Sci 112: 4415-4423, 1999.
178. HYAFIL F, MORELLO D, BABINET C, AND JACOB F. A cell surface glycoprotein involved in the compaction of embryonal carcinoma cells and cleavage stage embryos. Cell 21: 927-934, 1980.
179. IHLE JN. Cytokine receptor signalling. Nature 377: 591-594, 1995.
180. IRBY RB, MAO W, COPPOLA D, KANG J, LOUBEAU JM, TRUDEAU W, KARL R, FUJITA DJ, JOVE R, AND YEATMAN TJ. Activating SRC mutation in a subset of advanced human colon cancers. Nat Genet 21: 187-190, 1999.
181. ISBERG RR AND FALKOW S. A single genetic locus encoded by Yersinia pseudo tuberculosis permits invasion of cultured animal cells by Escherichia coli K-12. Nature 317: 262-264, 1985.
182. ISLAM S, CAREY TE, WOLF GT, WHEELOCK MJ, AND JOHNSON KR. Expression of N-cadherin by human squamous carcinoma cells induces a scattered fibroblastic phenotype with disrupted cell-cell adhesion. J Cell Biol 135: 1643-1654, 1996.
183. ITOH K, YOSHIOKA K, AKEDO H, UEHATA M, ISHIZAKI T, AND NARUMIYA S. An essential part for Rho-associated kinase in the transcellular invasion of tumor cells. Nature Med 5: 221-225, 1999.
184. IWAO K, NAKAMORI S, KAMEYAMA M, IMAOKA S, KINOSHITA M, FUKUI T, ISHIGURO S, NAKAMURA Y, AND MIYOSHI Y. Activation of the β-catenin gene by interstitial deletions involving exon 3 in primary colorectal carcinomas without adenomatous polyposis coli mutations. Cancer Res 58: 1021-1026, 1998.
185. JANDA E, LEHMANN K, KILLISCH I, JECHLINGER M, HERZIG M, DOWNWARD J, BEUG H, AND GRÜNERT S. Ras and TGFβ cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways. J Cell Biol 156: 299-313, 2002.
186. JANJI B, MELCHIOR C, GOUON V, VALLAR L, AND KIEFFER N. Autocrine TGF-β-regulated expression of adhesion receptors and integrin-linked kinase in HT-144 melanoma cells correlates with their metastatic phenotype. Int J Cancer 83: 255-262, 1999.
187. JANSSENS B, GOOSSENS S, STAES K, GILBERT B, VAN, HENGEL J, COLPAERT C, BRUYNEEL E, MAREEL M, AND VAN ROY F. αT-catenin: a novel tissue-specific β-catenin-binding protein mediating strong cell-cell adhesion. J Cell Sci 114: 3177-3188, 2001.
188. JEFFERS M, FISCELLA M, WEBB CP, ANVER M, KOOCHEKPOUR S, AND VANDE WOUDE GF. The mutationally activated Met receptor mediates motility and metastasis. Proc Natl Acad Sci USA 95: 14417-14422, 1998.
189. JEFFERS M, SCHMIDT L, NAKAIGAWA N, WEBB CP, WEIRICH G, KISHIDA T, ZBAR B, AND VANDE WOUDE GF. Activating mutations for the met tyrosine kinase receptor in human cancer. Proc Natl Acad Sci USA 94: 11445-11450, 1997.
190. JEONG H, MASON SP, BARABÁ AL, AND OLTVAI ZN. Lethality and centrality in protein networks. Nature 411: 41-42, 2001.
191. JIANG WG, HISCOX S, MATSUMOTO K, AND NAKAMURA T. Hepatocyte growth factor/scatter factor, its molecular, cellular and clinical implications in cancer. Crit Rev Oncol Hematol 29: 209-248, 1999.
192. JOHNSEN M, LUND LR, ROMER J, ALMHOLT K, AND DANO K. Cancer invasion and tissue remodeling: common themes in proteolytic matrix degradation. Curr Opin Cell Biol 10: 667-671, 1998.
193. JOU TS AND NELSON WJ. Effects of regulated expression of mutant RhoA and Rac1 small GTPases on the development of epithelial (MDCK) cell polarity. J Cell Biol 142: 85-100, 1998.
194. KALLIONIEMI OP, WAGNER U, KONONEN J, AND SAUTER G. Tissue microarray technology for high-throughput molecular profiling of cancer. Hum Mol Genet 7: 657-662, 2001.
195. KAMATH L, MEYDANI A, FOSS F, AND KULIOPULOS A. Signaling from protease-activated receptor-1 inhibits migration and invasion of breast cancer cells. Cancer Res 61: 5933-5940, 2001.
196. KANAI Y, ODA T, TSUDA H, OCHIAI A, AND HIROHASHI S. Point mutation of the E-cadherin gene in invasive lobular carcinoma of the breast. Jpn J Cancer Res 85: 1035-1039, 1994.
197. KANTAK SS AND KRAMER RH. E-cadherin regulates anchorage-independent growth and survival in oral squamous cell carcinoma cells. J Biol Chem 273: 16953-16961, 1998.
198. KATO K, CHEN MC, NGUYEN M, LEHMANN FS, PODOLSKY DK, AND SOLL AH. Effects of growth factors and trefoil peptides on migration and replication in primary oxyntic cultures, Am J Physiol Gastrointest Liver Physiol 276: G1105-G1116, 1999.
199. KATZ D, ROTHSTEIN R, SCHNED A, DUNN J, SEAVER K, AND ANTONIOLI D. The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus. Am J Gastroenterol 93: 536-541, 1998.
200. KATZ M, DESPOMMIER DD, AND GWADZ RW. Parasitic Diseases. New York: Springer-Verlag, 1989.
201. KAWANISHI J, KATO J, SASAKI K, FUJII S, WATANABE N, AND NUTSU Y. Loss of E-cadherin-dependent cell-cell adhesion due to mutation of the β-catenin gene in a human cancer cell line, HSC-39. Mol Cell Biol 15: 1175-1181, 1995.
202. KAWASHIRI S, KUMAGAI S, KOJIMA K, HARADA H, AND YAMAMOTO E. Development of a new invasion and metastasis model of human oral squamous cell carcinomas. Oral Oncol Eur J Cancer 31B: 216-221, 1995.
203. KEELY P, PARISE L, AND JULIANO R. Integrins and GTPases in tumour cell growth, motility and invasion. Trends Cell Biol 8: 101-106, 1998.
204. KEILHACK H, HELLMAN U, VAN HENGEL J, VAN ROY F, GODOVAC-ZIMMERMANN J, ANB BÖHMER FD. The protein-tyrosine phosphatase SHP-1 binds to and desphosphorylates p120 catenin. J Biol Chem 275: 26376-26384, 2000.
205. KEIRSEBILCK A, BONNÉ S, STAES K, VAN HENGEL J, NOLLET F, REYNOLDS A, AND VAN ROY F. Molecular cloning of the human p120ctn catenin gene (CTNND1): expression of multiple alternatively spliced isoforms. Genomics 50: 129-146, 1998.
206. KELLER G, VOGELSANG H, BECKER I, HUTTER J, OTT K, CANDIDUS S, GRUNDEI T, BECKER KF, MUELLER J, SIEWERT JR, AND HöFLER H, Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutation. Am J Pathol 155: 337-342, 1999.
207. KERBEL RS. Tumor angiogenesis: past, present and the near future. Carcinogenesis 21: 505-515, 2000.
208. KERNÉIS S, BOGDANOVA A, KRAEHENBUHL JP, AND PRINGAULT E. Conversion by Peyer's patch lymphocytes of human enterocytes into M cells that transport bacteria. Science 277: 949-952, 1997.
209. KIM JB, ISLAM S, KIM YJ, PRUDOFF RS, SASS KM, WHEELOCK MJ, AND JOHNSON KR. N-cadherin extracellular repeat 4 mediates epithelial to mesenchymal transition and increased motility. J Cell Biol 151: 1193-1206, 2000.
210. KIM K, DANIELS KJ, AND HAY ED. Tissue-specific expression of β-catenin in normal mesenchyme and uveal melanomas and its effect on invasiveness. Exp Cell Res 245: 79-90, 1998.
211. KIM N, LAZAR JM, CUNHA BA, LIAO W, AND NUNNAGANTI V. Multivalvular endocarditis. Clin Microbiol Infect 6: 207-212, 2000.
212. KNUDSEN KA, FRANKOWSKI C, JOHNSON KR, AND WHEELOCK MJ. A role for cadherins in cellular signaling and differentiation. J Cell Biochem Suppl 30/31: 168-176, 1998.
213. KNUDSON AG. Hereditary cancer: theme and variations. J Clin Oncol 15: 3280-3287, 1997.
214. KOCKS C, MARCHAND JB, GOUIN E, D'HAUTEVILLE H, SANSONETTI PJ, CARLIER MF, AND COSSART P. The unrelated surface proteins ActA of Listeria monocytogenes and IcsA of Shigella flexneri are sufficient to confer actin-based motility on Listeria innocua and Escherichia coli respectively. Mol Microbiol 18: 413-423, 1995.
215. KOLLIGS FT, KOLUGS B, HAJRA KM, HU G, TANI M, CHO KR, AND FEARON ER. γ-Catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of β-catenin. Genes Dev 14: 1319-1331, 2000.
216. -/- colon carcinoma. Science 275: 1784-1787, 1997.
217. KOTELEVETS L, NOË V, BRUYNEEL E, MYSSIAKINE E, CHASTRE E, MAREEL M, AND GESPACH C. Inhibition by platelet-activating factor of Src-and hepatocyte growth factor-dependent invasiveness of intestinal and kidney epithelial cells. Phosphatidylinositol-3′-kinase is a critical mediator of tumor invasion. J Biol Chem 273: 14138-14145, 1998.
218. KOTELEVETS L, VAN HENGEL J, BRUYNEEL E, MAREEL M, VAN ROY F, AND CHASTRE E. The lipid phosphatase activity of PTEN is critical to stabilize intercellular junctions and revert invasiveness. J Cell Biol 155: 1129-1135, 2001.
219. KURODA S, FUKATA M, NAKAGAWA M, FUJII K, NAKAMURA T, OOKUBO T, IZAWA I, NAGASE T, NOMURA N, TANI H, SHOJI I, MATSUURA Y, YONEHARA S, AND KAIBUCHI K. Role of IQGAP1, a target of the small GTPases Cdc42 and Rac1, in regulation of E-cadherin-mediated cell-cell adhesion. Science 281: 832-835, 1998.
220. LABBÉ E, LETAMENDIA A, AND ATTISANO L. Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-β and Wnt pathways. Proc Natl Acad Sci USA 97: 8358-8363, 2000.
221. LACROIX M, MARIE PJ, AND BODY JJ. Protein production by osteoblasts: modulation by breast cancer cell-derived factors. Breast Cancer Res Treat 61: 59-67, 2000.
222. LAI JF, KAO SC, JIANG ST, TANG MJ, CHAN PC, AND CHEN HC. Involvement of focal adhesion kinase in hepatocyte growth factor-induced scatter of Madin-Darby canine kidney cells, J Biol Chem 275: 7474-7480, 2000.
223. LALANI EN, WILLIAMS R, JAYARAM Y, GILBERT C, CHAUDHARY KS, SIU LS, KOUMARIANOU A, PLAYFORD R, AND STAMP GWH. Trefoil factor-2, human spasmolytic polypeptide, promotes branching morphogenesis in MCF-7 cells. Lab Invest 79: 537-546, 1999.
224. LARUE L, OHSUGI M, HIRCHENHAIN J, AND KEMLER R. E-cadherin null mutant embryos fail to form a trophectoderm epithelium. Proc Natl Acad Sci USA 91: 8263-8267, 1994.
225. LAUWAET T, OLIVEIRA MJ, MAREEL M, AND LEROY A. Molecular mechanisms of invasion by cancer cells, leukocytes and microorganisms. Microbes Infection 2: 923-931, 2000.
226. LAWRENCE PA. The Making of a Fly: The Genetics of Animal Design. Oxford, UK: Blackwell Scientific, 1992.
227. LECUIT M, DRAMSI S, GOTTARDI C, FEDOR-CHAIKEN M, GUMBINER B, AND COSSART P. A single amino acid in E-cadherin responsible for host specificity towards the human pathogen Listeria monocytogenes. EMBO J 18: 3956-3963, 1999.
228. LECUIT M, OHAYON H, BRAUN L, MENGAUD J, AND COSSART P. Internalin of Listeria monocytogenes with an intact leucine-rich repeat region is sufficient to promote internalization. Infect Immun 65: 5309-5319, 1997.
229. LECUIT M, VANDORMAEL-POURNIN S, LEFORT J, HUERRE M, GOUNON P, DUPUY C, BABINET C, AND COSSART P. A transgenic model for listeriosis: role of internalin in crossing the intestinal barrier. Science 292: 1722-1725, 2001.
230. LE DOUARIN NM AND ZILLER C. Plasticity in neural crest cell differentiation. Curr Opin Cell Biol 5: 1036-1043, 1993.
231. LEE JH, HAN SU, CHO H, JENNINGS B, GERRARD B, DEAN M, SCHMIDT L, ZBAR B, AND VANDE WOUDE GF. A novel germ line juxtamembrane Met mutation in human gastric cancer. Oncogene 19: 4947-4953, 2000.
232. LEFEBVRE O, CHENARD MP, MASSON R, LINARES J, DIERICH A, LEMEUR M, WENDLING C, TOMASETTO C, CHAMBON P, AND RIO MC. Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein. Science 274: 259-262, 1996.
233. LI J, YEN C, LIAW D, PODSYPANINA K, BOSE S, WANG SI, PUC J, MILLIARESIS C, RODGERS L, MCCOMBIE R, BIGNER SH, GIOVANELLA BC, ITTMANN M, TYCKO B, HIBSHOOSH H, WIGLER MH, AND PARSONS R. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275: 1943-1947, 1997.
234. LI Z, GALLIN WJ, LAUZON G, AND PASDAR M. L-CAM expression induces fibroblast-epidermoid transition in squamous carcinoma cells and down-regulates the endogenous N-cadherin. J Cell Sci 111: 1005-1019, 1998.
235. LICKERT H, BAUER A, KEMLER R, AND STAPPERT J. Casein kinase II phosphorylation of E-cadherin increases E-cadherin/β-catenin interaction and strengthens cell-cell adhesion, J Biol Chem 275: 5090-5095, 2000.
236. LIN SY, XIA W, WANG JC, KWONG KY, SPOHN B, WEN Y, PESTELL RG, AND HUNG MC. β-Catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression. Proc Natl Acad Sci USA 97: 4262-4266, 2000.
237. LIN YM, ONO K, SATOH S, ISHIGURO H, FUJITA M, MIWA N, TANAKA T, TSUNODA T, YANG KC, NAKAMURA Y, AND FURUKAWA Y. Identification of AF17 as a downstream gene of the β-catenin/T-cell factor pathway and its involvement in colorectal carcinogenesis. Cancer Res 61: 6345-6349, 2001.
238. LIOTTA LA AND KOHN EC. The microenvironment of the tumour-host interface. Nature 411: 375-379, 2001.
239. LIU D, EL-HARIRY I, KARAYIANNAKIS AJ, WILDING J, CHINERY R, KMIOT W, MCCREA PD, GULLICK WJ, AND PIGNATELLI M. Phosphorylation of β-catenin and epidermal growth factor receptor by intestinal trefoil factor. Lab Invest 77: 557-563, 1997.
240. LIU H, CHAO D, NAKAYAMA EE, TAGUCHI H, GOTO M, XIN X, TAKAMATSU JK, SAITO H, ISHIKAWA Y, AKAZA T, JUJI T, TAKEBE Y, OHISHI T, FUKUTAKE K, MARUYAMA Y, YASHIKI S, SONODA S, NAKAMURA T, NAGAI Y, IWAMOTO A, AND SHIODA T. Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression. Proc Nalt Acad Sci USA 96: 4581-4585, 1999.
241. LUKASHEV ME AND WERB Z. ECM signalling: orchestrating cell behaviour and misbehaviour. Trends Cell Biol 8: 437-441, 1998.
242. MACHADO JC, NOGUEIRA AMMF, CARNEIRO F, REIS CA, AND SOBRINHO-SIMÕES M. Gastric carcinoma exhibits distinct types of cell differentiation: an inummohistochemical study of trefoil peptides (TFF1 and TFF2) and mucins (MUC1, MUC2, MUC5AC, and MUC6). J Pathol 190: 437-443, 2000.
243. MACKAY DJG AND HALL A. Rho GTPases. J Biol Chem 273: 20685-20688, 1998.
244. MANIOTIS AJ, FOLBERG R, HESS A, SEFTOR EA, GARDNER LMG, PE'ER J, TRENT JM, MELTZER PS, AND HENDRIX MJC. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol 155: 739-752, 1999.
245. MANN B, GELOS M, SIEDOW A, HANSKI ML, GRATCHEV A, ILYAS M, BODMER WF, MOYER MP, RIECKEN FO, BUHR HJ, AND HANSKI C. Target genes of β-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas. Proc Natl Acad Sci USA 96: 1603-1608, 1999.
246. MAREEL MM, BEHRENS J, BIRCHMEIER W, DE BRUYNE GK, VLEMINCKX K, HOOGEWlJS A, FIERS WC, AND VAN ROY FM. Downregulation of Ecadherin expression in Madin Darby canine kidney (MDCK) cells inside nude mice tumors. Int J Cancer 47: 922-928, 1991.
247. MAREEL MM AND BRACKE ME. Molecular mechanisms of cancer invasion. In: Encyclopedia of Cancer (2nd ed.), edited by Bertino JR. New York: Academic, 2002, vol. 3, p. 221-233.
248. MAREEL M, BRACKE M, VAN ROY F, AND VAKAET L. Expression of E-cadherin in embryogenetic ingression and cancer invasion. Int J Dev Biol 37: 227-235, 1993.
249. MAREEL MM, DE BAETSELIER P, AND VAN ROY FM. Mechanisms of Invasion and Metastasis. Boca Raton, FL: CRC, 1991.
250. MAREEL MM AND VAN ROY FM. Are oncogenes involved in invasion and metastasis? Anticancer Res 6: 419-436, 1986.
251. MAREEL MM, VAN ROY FM, AND BRACKE ME. How and when do tumor cells metastasize? Crit Rev Oncog 4: 559-594, 1993.
252. MAREEL M, VAN ROY F, DE BAETSELIER P, AND VAKAET L. Invasiveness in development and neoplasia. In: Developmental Biology and Cancer, edited by Hodges GM and Rowlatt C. New Jersey: Telford, 1994, p. 389-416.
253. MAREEL M, VLEMINCKX K, VERMEULEN S, GAO Y, VAKAET L JR, BRACKE M, AND VAN ROY F. Homotypic cell-cell adhesion molecules and tumor invasion. In: Progress in Histo- and Cytochemistry, edited by Graumann W and Drukker J. Stuttgart, Germany: Fischer Verlag, 1992, vol. 26, p. 95-106.
254. MARINISSEN MJ AND GUTKIND JS. G-protein-coupled receptors and signaling networks: emerging paradigms. Trends Pharmacol Sci 22: 368-376, 2001.
255. MARIOTTI A, KEDESHIAN PA, DANS M, CURATOLA AM, GAGNOUX-PALACIOS L, AND GLANCOTTI FG. EGF-R signaling through Fyn kinase disrupts the function of integrin alpha6beta4 at hemidesmosomes: role in epithelial cell migration and carcinoma invasion. J Cell Biol 155: 447-458, 2001.
256. MARSHALL JF AND DAVIES D. The role of integrin-mediated processes in the biology of metastasis. In: Cancer Metastasis, Molecular and Cellular Mechanisms and Clinical Intervention, edited by Jiang WG and Mansel RE. Dordrecht, The Netherlands: Kluwer Academic, 2000, p. 19-54.
257. MARTEL C, HARPER F, CEREGHINI S, NOË V, MAREEL M, AND CRÉMISI C. Inactivation of retinoblastoma family proteins by SV40 T antigen results in creation of a hepatocyte growth factor/scatter factor autocrine loop associated with an epithelial-fibroblastoid conversion and invasiveness. Cell Growth Differ 8: 165-178, 1997.
258. MARTEL C, LALLEMAND D, AND CRÉMISI C. Specific c-myc and max regulation in epithelial cells. Oncogene 10: 2195-2205, 1995.
259. MARTIN GS. The hunting of the Src. Nat Mol Cell Biol 2: 467-475, 2001.
260. MARTIN M, PUJUGUET P, AND MARTIN F. Role of stromal myofibroblasts infiltrating colon cancer in tumor invasion. Pathol Res Pract 192: 712-717, 1996.
261. MASHIMO H, WU DC, PODOLSKY DK, AND FISHMAN MC. Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor. Science 274: 262-265, 1996.
262. MASTERS JR, THOMSON JA, DALY-BURNS B, REID YA, DIRKS WG, PACKER P, TOJI LH, OHNO T, TANABE H, ARLETT CF, KELLAND LR, HARRISON M, VIRMANI A, WARD TH, AYRES KL, AND DEBENHAM PG. Short tandem repeat profiling provides an international reference standard for human cell lines. Proc Natl Acad Sci USA 98: 8012-8017, 2001.
263. MATSUBARA A, KAN M, FENG S, AND MCKEEHAN WL. Inhibition of growth of malignant rat prostate tumor cells by restoration of fibroblast growth factor receptor 2. Cancer Res 58: 1509-1514, 1998.
264. MATSUMOTO K AND NAKAMURA T. Hepatocyte growth factor and met in tumour invasion-metastasis: from mechanisms to cancer prevention. In: Cancer Metastasis, Molecular and Cellular Mechanisms and Clinical Intervention, edited by Jiang WG and Mansel RE. Dordrecht, The Netherlands: Kluwer Academic, 2000, p. 143-193.
265. MATSUMOTO K AND NAKAMURA T. HGF-c-Met receptor pathway in tumor invasion-metastasis and potential cancer treatment with NK4. In: Growth Factors and Their Receptors in Cancer Metastasis, edited by Jiang WG, Matsumoto K, and Nakamura T. Dordrecht, The Netherlands: Kluwer Academic, 2001, p. 241-276.
266. MCCARTNEY BM AND PEIFER M. Teaching tumour suppressors new tricks. Nat Cell Biol 2: E58-E60, 2000.
267. MCCAWLEY LJ AND MATRISIAN LM. Matrix metalloproteinases: multi-functional contributors to tumor progression. Mol Med Today 6: 149-156, 2000.
268. MENGAUD J, DRAMSI S, GOUIN E, VAZQUEZ-BOLAND JA, MILON G, AND COSSART P. Pleiotropic control ofListeria monocytogenes virulence factors by a gene that is autoregulated. Mol Microbiol 9: 2273-2283, 1991.
269. MENGAUD J, OHAYON H, GOUNON P, MÉGE RM, AND COSSART P. E-cadherin is the receptor for internalin, a surface protein required for entry of L. monocytogenes into epithelial cells. Cell 84: 923-932, 1996.
270. MERCURIO AM AND RABINOVITZ I. Towards a mechanistic understanding of tumor invasion-lessons from the alpha 6 beta 4 integrin. Semin Cancer Biol 11: 129-141, 2001.
271. MEZA I. Extracellular matrix-induced signaling in Entamoeba histolytica: its role in invasiveness. Parasitol Today 16: 23-28, 2000.
272. MICHIELS F AND COLLARD JG. Rho-like GTPases: their role in cell adhesion and invasion. Biochem Soc Symp 65: 125-146, 1999.
273. MIETTINEN PJ, EBNER R, LOPEZ AR, AND DERYNCK R. TGF-β induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors. J Cell Biol 127: 2021-2036, 1994.
274. MIGNATTI P AND RIFKIN DB. Biology and biochemistry of proteinases in tumor invasion. Physiol Rev 73: 161-195, 1993.
275. MIYATA M, SHIOZAKI H, KOBAYASHI K, YANO H, TAMURA S, TAHARA H, AND MORI T. Correlation between expression of E-cadherin and metastases in human esophageal cancer: preliminary report. Nippon Geka Gakkai Zasshi 91: 1761, 1990.
276. MOLL R, MITZE M, FRIXEN UH, AND BIRCHMEIER W. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. Am J Pathol 143: 1731-1742, 1993.
277. MONTESANO R, MATSUMOTO K, NAKAMURA T, AND ORCI L. Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell 67: 901-908, 1991.
278. MORONY S, CAPPARELLI C, SAROSI I, LACEY DL, DUNSTAN CR, AND KOSTENUIK PJ. Osteoprotegerin inhibits osteolysis and decreases skeletal tumor burden in syngeneic and nude mouse models of experimental bone metastasis. Cancer Res 61: 4432-4436, 2001.
279. MOTTRAM JC. cdc2-related protein kinases and cell cycle control in trypanosomatids. Parasitol Today 10: 253-257, 1994.
280. MÜLLER A, HOMEY B, SOTO H, GE N, CATRON D, BUCHANAN ME, MCCLANAHAN T, MURPHY E, YUAN W, WAGNER SN, BARRERA JL, MOHAR A, VERÁSTEGUI E, AND ZLOTNIK A. Involvement of chemokine receptors in breast cancer metastasis. Nature 410: 50-56, 2001.
281. MÜLLER T, CHOIDAS A, REICHMANN E, AND ULLRICH A. Phosphorylation and free pool of β-catenin are regulated by tyrosine kinases and tyrosine phosphatases during epithelial cell migration. J Biol Chem 274: 10173-10183, 1999.
282. MUNDY G. Preclinical models of bone metastases. Semin Oncol 28: 2-8, 2001.
283. MUNEMITSU S, ALBERT I, SOUZA B, RUBINFELD B, AND POLAKIS P. Regulation of intracellular β-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. Proc Natl Acad Sci USA 92: 3046-3050, 1995.
284. MYERS MP, PASS I, BATTY IH, VAN DER KAAY J, STOLAROV JP, HEMMINGS BA, WIGLER MH, DOWNES CP, AND TONKS NK. The lipid phosphatase activity of PTEN is critical for its tumor suppressor function. Proc Natl Acad Sci USA 95: 13513-13518, 1998.
285. NAGENGAST FM, GRUBBEN MJAL, AND VAN MUNSTER IP. Role of bile acids in colorectal carcinogenesis. Eur J Cancer 31A: 1067-1070, 1995.
286. NALDINI L, WEIDNER KM, VIGNA E, GAUDINO G, BARDELLI A, PONZETTA C, NARSIMHAN RP, HARTMANN G, ZARNEGAR R, MICHALOPOULOS GK, BIRCHMEIER W, AND COMOGLIO PM. Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor. EMBO J 10: 2867-2878, 1991.
287. NATSUGOE S, MUELLER J, KIJIMA F, ARIDOME K, SHIMADA M, SHIRAO K, KUSANO C, BABA M, YOSHINAKA H, FUKUMOTO T, AND AIKOU T. Extranodal connective tissue invasion and the expression of desmosomal glycoprotein 1 in squamous cell carcinoma of the oesophagus. Br J Cancer 75: 892-897, 1997.
288. NG YY, HUANG TP, YANG WC, CHEN ZP, YANG AH, MU W, NIKOLIC-PATERSON DJ, ATKINS RC, AND LAN HY. Tubular epithelial-myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats. Kidney Int 54: 864-876, 1998.
289. NGUYEN QD, FAIVRE S, BRUYNEEL E, RIVAT C, SETO M, ENDO T, MAREEL M, EMAMI S, AND GESPACH C. RhoA- and RhoD dependent regulatory switch of Gα-subunits signaling by PAR-1 receptors in cellular invasion. FASEB J 16: 565-576, 2002.
290. NIEMAN MT, ETHIER SP, JOHNSON KR, AND WHEELOCK MJ. N-cadherin expression promotes invasive phenotype in breast carcinoma cell lines. Proc Am Assoc Cancer Res 39: 400, 1998.
291. NIEMAN MT, PRUDOFF RS, JOHNSON KR, AND WHEELOCK MJ. N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. J Cell Biol 147: 631-643, 1999.
292. NIEVERS MG, SCHAAPVELD RQ, AND SONNENBERG A. Biology and function of hemidesmosomes. Matrix Biol 18: 5-17, 1999.
293. NOBES CD AND HALL A. Rho GTPases control polarity, protrusion, and adhesion during cell movement. J Cell Biol 144: 1235-1244, 1999.
294. NOË V, CHASTRE E, BRUYNEEL E, GESPACH C, AND MAREEL M. Extracellular regulation of cancer invasion: the E-cadherin/catenin and other pathways. Biochem Soc Symp 65: 43-62, 1999..
295. NOË V, FINGLETON B, JACOBS K, CRAWFORD HC, VERMEULEN S, STEELANT W, BRUYNEEL E, MATRISIAN LM, AND MAREEL M. Release of an invasion promotor E-cadherin fragment by matrilysin and stromelysin-1. J Cell Sci 114: 111-118, 2001.
296. NOË V, WILLEMS J, VANDEKERCKHOVE J, VAN ROY F, BRUYNEEL E, AND MAREEL M. Inhibition of adhesion and induction of epithelial cell invasion by HAV-containing E-cadherin-specific peptides. J Cell Sci 112: 127-135, 1999.
297. NOËL A, GILLES C, BAJOU K, DEVY L, KEBERS F, LEWALLE JM, MAQUOI E, MUNAUT C, REMACLE A, AND FOIDART JM. Emerging roles for proteinases in cancer. Invasion Metastasis 17: 221-239, 1997.
298. NOLLET F, BERX G, AND VAN ROY F. The role of the E-cadherin/catenin adhesion complex in the development and progression of cancer. Mol Cell Biol Res Commun 2: 77-85, 1999.
299. NOLLET F, KOOLS P, AND VAN ROY F. Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members. J Mol Biol 299: 551-572, 2000.
300. NOLLET F, VAN HENGEL J, BERX G, MOLEMANS F, AND VAN ROY F. Isolation and characterization of a human pseudogene (CTNNAP1) for αE-catenin (CTNNA1): assignment of the pseudogene to 5q22 and the αE-catenin gene to 5q31. Genomics 26: 410-413, 1995.
301. NOREN NK, LIU BP, BURRIDGE K, AND KREFT B. p120 Catenin regulates the actin cytoskeleton via Rho family GTPases. J Cell Biol 150: 567-579, 2000.
302. ODA H, TSUKITA S, AND TAKEICHI M. Dynamic behavior of the cadherin-based cell-cell adhesion system during Drosophila gastrulation. Dev Biol 203: 435-450, 1998.
303. OFT M. TGFβ receptor signaling in cancer and metastasis. In: Growth Factors and Their Receptors in Cancer Metastasis, edited by Jiang WG, Matsumoto K, and Nakamura T. Dordrecht, The Netherlands: Kluwer Academic, 2001, p. 187-222.
304. OKA H, SHIOZAKI H, KOBAYASHi K, INOUE M, TAHARA H, KOBAYASHI T, TAKATSUKA Y, MATSUYOSHI N, HIRANO S, TAKEICHI M, AND MORI T. Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res 53: 1696-1701, 1993.
305. OKA H, SHIOZAKI H, KOBAYASHI K, TAHARA H, TAMURA S, YAMAZAKI K, AND MORI T. Immunoreactive expression of E-cadherin in human gastric cancer: preliminary report. Nippon Geka Gakkai Zasshi 91: 1814, 1990.
306. OKADA-BAN M, MOENS G, THIERY JP, AND JOUANNEAU J. Nuclear 24 kD fibroblast growth factor (FGF)-2 confers metastatic properties on rat bladder carcinoma cells. Oncogene 18:6719-6724, 1999.
307. OMELCHENKO T, FETISOVA E, IVANOVA O, BONDER EM, FEDER H, VASILIEV JM, AND GELFAND IM. Contact interactions between epitheliocytes and fibroblasts: formation of heterotypic cadherin-containing adhesion sites is accompanied by local cytoskeletal reorganization. Proc Natl Acad Sci USA 98: 8632-8637, 2001.
308. OPDENAKKER G AND VAN DAMME J. Chemotactic factors, passive invasion and metastasis of cancer cells. Immunol Today 13: 463-464, 1992.
309. O'REILLY MS, HOLMGREN L, SHING Y, CHEN C, ROSENTHAL RA, MOSES M, LANE WS, CAO Y, SAGE EH, AND FOLKMAN J. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79: 315-328, 1994.
310. OYAMA, T, KANAI Y, OCHIAI A, AKIMOTO S, ODA T, YANAGIHARA K, NAGAFUCHI A, TSUKITA S, SHIBAMOTO S, ITO F, TAKEICHI M, MATSUDA H, AND HIROHASHI S. A truncated β-catenin disrupts the interaction between E-cadherin and a-catenin: a cause of loss of intercellular adhesiveness in human cancer cell lines. Cancer Res 54: 6282-6287, 1994.
311. OZAWA M, BARIBAULT H, AND KEMLER R. The cytoplasmic domain of the cell adhesion molecule uvomorulin associates with three independent proteins structurally related in different species. EMBO J 8: 1711-1717, 1989.
312. OZAWA M AND KEMLER R. The membrane-proximal region of the E-cadherin cytoplasmic domain prevents dimerization and negatively regulates adhesion activity. J Cell Biol 142: 1605-1613, 1998.
313. PAGET S. The distribution of secondary growths in cancer of the breast. Lancet 1: 571-573, 1889.
314. PALAZZO AF, COOK TA, ALBERTS AS, AND GUNDERSEN GG. mDia mediates Rho-regulated formation and orientation of stable microtubules. Nat Cell Biol 3: 723-729, 2001.
315. PANTALONI D, LE CLAINCHE C, AND CARLIER MF. Mechanism of actinbased motility. Science 292: 1502-1506, 2001.
316. PARK JE, LENTER MC, ZIMMERMANN RN, GARIN-CHESA P, OLD LJ, AND RETTIG WJ. Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts. J Biol Chem 274: 36505-36512, 1999.
317. PARSONS JT, MARTIN KH, SLACK JK, TAYLOR JM, AND WEED SA. Focal adhesion kinase: a regulator of focal adhesion dynamics and cell movement. Oncogene 19: 5606-5613, 2000.
318. PATTI JM AND HÖÖK M. Microbial adhesins recognizing extracellular matrix macromolecules. Curr Opin Cell Biol 6: 752-758, 1994.
319. PERL AK, WILGENBUS P, DAHL U, SEMB H, AND CHRISTOFORI G. A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 392: 190-193, 1998.
320. PETRI WA JR, CLARK CG, BRAGA LL, AND MANN BJ. International seminar on amebiasis. Parasitol Today 9: 73-76, 1993.
321. PETRI WA JR, HAQUE R, LYERLY D, AND VINES RR. Estimating the impact of amebiasis on health. Parasitol Today 16: 320-321, 2000.
322. PHILLIPS AO, TOPLEY N, MORRISEY K, WILLIAMS JD, AND STEADMAN R. Basic fibroblast growth factor stimulates the release of preformed transforming growth factor β1 from human proximal tubular cells in the absence of de novo gene transcription or mRNA translation. Lab Invest 76: 591-600, 1997.
323. PIEDRA J, MARTÍNEZ D, CASTAÑO J, MIRAVET S, DUÑACH M, AND GARCÍA DE HERREROS A. Regulation of β-catenin structure and activity by tyrosine phosphorylation. J Biol Chem 276: 20436-20443, 2001.
324. PLAYFORD RJ, MARCHBANK T, CHINERY R, EVISON R, PIGNATELLI M, BOULTON RA, THIM L, AND HANBY AM. Human spasmolytic polypeptide is a cytoprotective agent that stimulates cell migration. Gastroenterology 108: 108-116, 1995.
325. POCARD M, DEBRUYNE P, BRAS-GONÇALVES R, MAREEL M, DUTRILLAUX B, AND POUPON MF. Single alteration of p53 or E-cadherin genes can alter the surgical resection benefit in an experimental model of colon cancer. Dis Colon Rectum 44: 1106-1112, 2001.
326. POLAKIS P. The adenomatous polyposis coli (APC) tumor suppressor. Biochim Biophys Acta 1332: F127-F147, 1997.
327. PONZETTO C, BARDELLI A, ZHEN Z, MAINA F, DALLA ZONCA P, GIORDANO S, GRAZIANI A, PANAYOTOU G, AND COMOGLIO PM. A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family. Cell 77: 261-271, 1994.
328. PRUNIER C, MAZARS A, NOË V, BRUYNEEL E, MAREEL M, GESPACH C, AND ATFI A. Evidence that Smad2 is a tumor suppressor implicated in the control of cellular invasion. J Biol Chem 274: 22919-22922, 1999.
329. QUE X AND REED SL. The role of extracellular cysteine proteinases in pathogenesis of Entamoeba histolytica invasion. Parasitol Today 13: 190-194, 1997.
330. RASHEED BKA, STENZEL TT, MCLENDON RE, PARSONS R, FRIEDMAN AH, FRIEDMAN HS, BIGNER DD, AND BIGNER SH. PTEN gene mutations are seen in high-grade but not in low-grade gliomas. Cancer Res 57: 4187-4190, 1997.
331. REBEL JMJ, THIJSSEN CDEM, VERMEY M, DELOUVÉE A, ZWARTHOFF EC, AND VAN DER KWAST TH. E-cadherin expression determines the mode of replacement of normal urothelium by human bladder carcinoma cells. Cancer Res 54: 5488-5492, 1994.
332. REDDY BS, WATANABE K, WEISBURGER JH, AND WYNDER EL. Promoting effect of bile acids in colon carcinogenesis in germ-free and conventional F344 rats. Cancer Res 37: 3228-3242, 1977.
333. REMUZZI A AND GIAVAZZI R. Adhesion of tumor cells under flow. Methods Mol Biol 96: 153-157, 1999.
334. REYA T, MORRISON SJ, CLARKE MF, AND WEISSMAN IL. Stem cells, cancer, and cancer stem cells. Nature 414: 105-111, 2001.
335. RIEGER-CHRIST KM, CAIN JW, BRAASCH JW, DUGAN JM, SILVERMAN ML, BOUYOUNES B, LIBERTINO JA, AND SUMMERHAYES IC. Expression of classic cadherins type I in urothelial neoplastic progression. Hum Pathol 32: 18-23, 2001.
336. RIEHL R, JOHNSON K, BRADLEY R, GRUNWALD GB, CORNEL E, LILIENBAUM A, AND HOLT CE. Cadherin function is required for axon outgrowth in retinal ganglion cells in vivo. Neuron 17: 837-848, 1996.
337. RIMM DL, KOSLOV ER, KEBRINEI P, AND MORROW JS. α-Catenin binds to both actin and β-catenin: potential linkage of the cadherin complex to the cytoskeleton. J Biocellular Biochem 19B: 138, 1995.
338. RODRIGUES S, NGUYEN QD, FAIVRE S, BRUYNEEL E, THIM L, WESTLEY B, MAY F, FLATAU G, MAREEL M, GESPACH C, AND EMAMI S. Activation of cellular invasion by trefoil peptides and src is mediated by cyclooxygenase- and thromboxane A2 receptor-dependent signaling pathways. FASEB J 15: 1517-1528, 2001.
339. ROSAM AC, WALLACE JL, AND WHITTLE JR. Potent ulcerogenic actions of platelet-activating factor on the stomach. Nature 319: 54-56, 1986.
340. ROSATO R, VELTMAAT JM, GROFFEN J, AND HEISTERKAMP N. Involvement of the tyrosine kinase Fer in cell adhesion. Mol Cell Biol 18: 5762-5770, 1998.
341. RUBINFELD B, SOUZA B, ALBERT I, MULLER O, CHAMBERLAIN SH, MASIARZ FR, MUNEMITSU S, AND POLAKIS P. Association of the APC gene product with beta-catenin. Science 262: 1731-1734, 1993.
342. RUNSWICK SK, O'HARE MJ, JONES L, STREULI CH, AND GARROD DR. Desmosomal adhesion regulates epithelial morphogenesis and cell positioning. Nat Cell Biol 3: 823-830, 2001.
343. RYNIERS F, STOVE C, GOETHALS M, BRACKENIER L, NOË V, BRACKE M, VANDEKERCKHOVE J, MAREEL M, AND BRUYNEEL E. Plasmin produces an E-cadherin fragment that stimulates cancer cell invasion. J Biol Chem 383: 159-165, 2002.
344. RYO A, NAKAMURA M, WULF G, LIOU YC, AND LU KP. Pin1 regulates turnover and subcellular localization of β-catenin by inhibiting its interaction with APC. Nat Cell Biol 3: 793-801, 2001.
345. RYU B, JONES J, HOLLINGSWORTH MA, HRUBAN RH, AND KERN SE. Invasion-specific genes in malignancy: serial analysis of gene expression comparisons of primary and passaged cancers. Cancer Res 61: 1833-1838, 2001.
346. SALYERS AA AND WHITT DD (Editors). Bacterial Pathogenesis: a Molecular Approach. Washington, DC: ASM, 1994.
347. SANDER EE AND COLLARD JG. Rho-like GTPases: their role in epithelial cell-cell adhesion and invasion. Eur J Cancer 35: 1302-1308, 1999.
348. SANDS BE AND PODOLSKY DK. The trefoil peptide family. Annu Rev Physiol 58: 253-273, 1996.
349. SANSONETTI PJ, MOUNIER J, PRÉVOST MC, AND MÈGE RM. Cadherin expression is required for the spread of Shigella flexneri between epithelial cells. Cell 76: 829-839, 1994.
350. SAUNDERS MM, SERAJ MJ, LI Z, ZHOU Z, WINTER CR, WELCH DR, AND DONAHUE HJ. Breast cancer metastatic potential correlates with a breakdown in homospecific and heterospecific gap junctional intercellular communication. Cancer Res 61: 1765-1767, 2001.
351. 2+ sensitization of contraction in vascular smooth muscle. J Biol Chem 275: 21722-21729, 2000.
352. SAVAGNER P, VALLÉS AM, JOUANNEAU J, YAMADA KM, AND THIERY JP. Alternative splicing in fibroblast growth factor receptor 2 is associated with induced epithelial-mesenchymal transition in rat bladder carcinoma cells. Mol Biol Cell 5: 851-862, 1994.
353. SCHIPPER JH, FRIXEN UH, BEHRENS J, UNGER A, JAHNKE K, AND BIRCHMEIER W. E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis. Cancer Res 51: 6328-6337, 1991.
354. SCHLECH WF III. Food-borne listeriosis. Clin Infect Dis 31: 770-775, 2000.
355. SCHLEICH AB, FRICK M, AND MAYER A. Patterns of invasive growth in vitro. Human decidua graviditatis confronted with established human cell lines and primary human explants. J Natl Cancer Inst 56: 221-237, 1976.
356. SCHMIDT L, DUH FM, CHEN F, KISHIDA T, GLENN G, CHOYKE P, SCHERER SW, ZHUANG Z, LUBENSKY I, DEAN M, ALLIKMETS R, CHIDAMBARAM A, BERGERHEIM UR, FELTIS JT, CASADEVALL C, ZAMARRON A, BERNUES M, RICHARD S, LIPS CJ, WALTHER MM, TSUI LC, GEIL L, ORCUTT ML, STACKHOUSE T, LIPAN J, SLIFE L, BRAUCH H, DECKER J, NIEHANS G, HUGHSON MD, MOCH H, STORKEL S, LERMAN MI, LINEHAN WM, AND ZBAR B. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat Genet 16: 68-73, 1997.
357. SCHWARTZ MA. Integrins, oncogenes, and anchorage independence. J Cell Biol 139: 575-578, 1997.
358. SCHWARTZ MA AND INGBER DE. Integrating with integrins. Mol Biol Cell 5: 389-393, 1994.
359. SCHWINDINGER WF AND ROBISHAW JD. Heterotrimeric G-protein βγ-dimers in growth and differentiation. Oncogene 20: 1653-1660, 2001.
360. SCOTTON CJ, WILSON JL, MILLIKEN D, STAMP G, AND BALKWILL FR. Epithelial cancer cell migration: a role for chemokine receptors? Cancer Res 61: 4961-4965, 2001.
361. SEFTOR RE, SEFTOR EA, AND HENDRIX MJ. Molecular role(s) for integrins in human melanoma invasion. Cancer Metastasis Rev 18: 359-375, 1999.
362. SHEN Y, NAUJOKAS M, PARK M, AND IRETON K. InIB-dependent internalization of Listeria is mediated by the Met receptor tyrosine kinase. Cell 103: 501-510, 2000.
363. SHIBAMOTO S, HAYAKAWA M, TAKEUCHI K, HORI T, OKU N, MIYAZAWA K, KITAMURA N, TAKEICHI M, AND ITO F. Tyrosine phosphorylation of β-catenin and plakoglobin enhanced by hepatocyte growth factor and epidermal growth factor in human carcinoma cells. Cell Adhesion Commun 1: 295-305, 1994.
364. SHINOHARA M, HIRAKI A, IKEBE T, NAKAMURA S, KURAHARA SI, SHIRASUNA K, AND GARROD DR. Immunohistochemical study of desmosomes in oral squamous cell carcinoma: correlation with cytokeratin and E-cadherin staining, and with tumour behaviour. J Pathol 184: 369-381, 1998.
365. SHIOZAKI H, KADOWAKI T, DOKI Y, INOUE M, TAMURA S, OKA H, IWAZAWA T, MATSUI S, SHIMAYA K, TAKEICHI M, AND MORI T. Effect of epidermal growth factor on cadherin-mediated adhesion in a human oesophageal cancer cell line. Br J Cancer 71: 250-258, 1995.
366. SHIOZAKI H, TAHARA H, OKA H, MIYATA M, KOBAYASHI K, TAMURA S, IIHARA K, DOKI Y, HIRANO S, TAKEICHI M, AND MORI T. Expression of immunoreactive E-cadherin adhesion molecules in human cancers. Am J Pathol 139: 17-23, 1991.
367. SIMON-ASSMANN P AND KEDINGER M. Tissue recombinants to study extracellular matrix targeting to basement membranes. Methods Mol Biol 139: 311-319, 2000.
368. SKOBE M, HAWIGHORST T, JACKSON DG, PREVO R, JANES L, VELASCO P, RICCARDI L, ALITALO K, CLAFFEY K, AND DETMAR M. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nature Med 7: 192-198, 2001.
369. SKOBE M, ROCKWELL P, GOLDSTEIN N, VOSSELER S, AND FUSENIG NE. Halting angiogenesis suppresses carcinoma cell invasion. Nature Med 3: 1222-1227, 1997.
370. SMITH GA, PORTNOY DA, AND THERIOT JA. Asymmetric distribution of the Listeria monocytogenes ActA protein is required and sufficient to direct actin-based motility. Mol Microbiol 17: 945-951, 1995.
371. SMITH GA, THERIOT JA, AND PORTNOY DA. The tandem repeat domain in the Listeria monocytogenes ActA protein controls the rate of actin-based motility, the percentage of moving bacteria, and the localization of vasodilator-stimulated phosphoprotein and profilin. J Cell Biol 135: 647-660, 1996.
372. SOBIN LH AND WITTEKIND C (Editors). TNM. Classification of Malignant Tumours (5th ed.). New York: Wiley, 1997.
373. SOMERS WS, TANG J, SHAW GD, AND CAMPHAUSEN RT. Insights into the molecular basis of leukocyte tethering and rolling revealed by structures of P- and E-selectin bound to SLe(X) and PSGL-1. Cell 103: 467-479, 2000.
374. SPANCAKE KM, ANDERSON CB, WEAVER VM, MATSUNAMI N, BISSELL M, AND WHITE RL. E7-transduced human breast epithelial cells show partial differentiation in three-dimensional culture. Cancer Res 59: 6042-6045, 1999.
375. SPÄTH GF AND WEISS MC. Hepatocyte nuclear factor 4 provokes expression of epithelial marker genes, acting as a morphogen in dedifferentiated hepatoma cells. J Cell Biol 140: 935-946, 1998.
376. SPRINGER TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76: 301-314, 1994.
377. STAUDINGER JL, GOODWIN B, JONES SA, HAWKINS-BROWN D, MACKENZIE KI, LATOUR A, LIU Y, KLAASSEN CD, BROWN KK, REINHARD J, WILLSON TM, KOLLER BH, AND KLIEWER SA. The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proc Natl Acad Sci USA 98: 3369-3374, 2001.
378. KIP1. J Cell Biol 142: 557-571, 1998.
379. STECK PA, PERSHOUSE MA, JASSER SA, YUNG WKA, LIN H, LIGON AH, LANGFORD LA, BAUMGARD ML, HATTIER T, DAVIS T, FRYE C, HU R, SWEDLUND B, TENG DHF, AND TAVTIGIAN SV. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 15: 356-362, 1997.
380. STEELANT WFA, GOEMAN JL, PHILIPPÉ J, OOMEN LCJM, HILKENS J, KRZEWlNSKI-RECCHI MA, HUET G, VAN DER EYCKEN J, DELANNOY P, BRUYNEEL EA, AND MAREEL MM. The alkyl-lysophospholipid 1-O-octadecyl-2-O-methyl-glycerophosphocholine induces invasion through episialin-mediated neutralization of E-cadherin in human mammary MCF-7 cells in vitro. Int J Cancer 92: 527-536, 2001.
381. STEHELIN D, VARMUS HE, BISHOP JM, AND VOGT PK. DNA related to the transforming gene(s) of avian sarcoma viruses is present in normal avian DNA. Nature 260: 170-173, 1976.
382. STEINHUSEN U, WEISKE J, BADOCK V, TAUBER R, BOMMERT K, AND OTMAR H. Cleavage and shedding of E-cadherin after induction of apoptosis. J Biol Chem 276: 4972-4980, 2001.
383. STOKER M, GHERARDI E, PERRYMAN M, AND GRAY J. Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature 327: 239-242, 1987.
384. STOLER AB, STENBACK F, AND BALMAIN A. The conversion of mouse skin squamous cell carcinomas to spindle cell carcinomas is a recessive event. J Cell Biol 122: 1103-1117, 1993.
385. STORME G AND MAREEL M. Effect of anticancer agents on directional migration of malignant C3H mouse fibroblastic cells in vitro. Cancer Res 40: 943-948, 1980.
386. STRUTZ F. Novel aspects of renal fibrogenesis. Nephrol Dial Transplant 10: 1526-1532, 1995.
387. Su LK, VOGELSTEIN B, AND KINZLER KW. Association of the APC tumor suppressor protein with catenins. Science 262: 1734-1737, 1993.
388. SULTANEM K, SHU HK, XIA P, AKAZAWA C, QUIVEY JM, VERHEY LJ, AND FU KK. Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California-San Francisco experience. Int J Radiat Oncol Biol Phys 48: 711-722, 2000.
389. SZPADERSKA AM AND FRANKFATER A. An intracellular form of cathepsin B contributes to invasiveness in cancer. Cancer Res 61: 3493-3500, 2001.
390. TAKEICHI M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science 251: 1451-1455, 1991.
391. TAMURA G, YIN J, WANG S, FLEISHER AS, ZOU T, ABRAHAM JM, KONG D, SMOLINSKI KN, WILSON KT, JAMES SP, SILVERBERG SG, NISHIZUKA S, TERASHIMA M, MOTOYAMA T, AND MELTZER SJ. E-cadherin gene promoter hypermethylation in primary human gastric carcinomas. J Natl Cancer Inst 92: 569-573, 2000.
392. TAMURA M, GU J, TAKINO T, AND YAMADA KM. Tumor suppressor PTEN inhibition of cell invasion, migration, and growth: differential involvement of focal adhesion kinase and p130Cas. Cancer Res 59: 442-449, 1999.
393. TAMURA M, Gu J, TRAN H, AND YAMADA KM. PTEN gene and integrin signaling in cancer. J Natl Cancer Inst 91: 1820-1828, 1999.
394. TANG A, AMAGAI M, GRANGER LG, STANLEY JR, AND UDEY MC. Adhesion of epidermal Langerhans cells to keratinocytes mediated by E-cadherin. Nature 361: 82-85, 1993.
395. TANG A, ELLER MS, HARA M, YAAR M, HIROHASHI S, AND GILCHREST BA. E-cadherin is the major mediator of human melanocyte adhesion to keratinocytes in vitro. J Cell Sci 107: 983-992, 1994.
396. TARTAGLIA LA, DEMBSKI M, WENG X, DENG N, CULPEPPER J, DEVOS R, RICHARDS RJ, CAMPFIELD LA, CLARK FT, DEEDS J, MUIR C, SANKER S, MORIARTY A, MOORE KJ, SMUTKO JS, MAYS GG, WOOLF EA, MONROE CA, AND TEPPER RI. Identification and expression cloning of a leptin receptor, OB-R. Cell 83: 1263-1271, 1995.
397. TAUPIN D, WU DC, JEON WK, DEVANEY K, WANG TC, AND PODOLSKY DK. The trefoil gene family are coordinately expressed immediate-early genes: EGF receptor-and MAP kinase-dependent interregulation. J Clin Invest 103: R31-R38, 1999.
398. TEJPAR S, NOLLET F, LI C, WUNDER JS, MICHILS G, DAL CIN P, VAN CUTSEM E, BAPAT B, VAN ROY F, CASSIMAN JJ, AND ALMAN BA. Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor). Oncogene 18: 6615-6620, 1999.
399. THIERY JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev 2: 442-454, 2002.
400. THIERY JP, DUBAND JL, AND DELOUVEE A. Pathways and mechanisms of avian trunk neural crest cell migration and lacalization. Dev Biol 93: 324-343, 1982.
401. THIM L, WÖLDIKE HF, NIELSEN PF, CHRISTENSEN M, LYNCH-DEVANEY K, AND PODOLSKY DK. Characterization of human and rat intestinal trefoil factor produced in yeast. Biochemistry 34: 4757-4764, 1995.
402. THOMAS SM AND BRUGGE JS. Cellular functions regulated by src family kinases. Annu Rev Cell Dev Biol 13: 513-609, 1997.
403. ctn from E-cadherin disrupts strong adhesion. J Cell Biol 148: 189-201, 2000.
404. TOKUNOU M, NIKI T, EGUCHI K, IBA S, TSUDA H, YAMADA T, MATSUNO Y, KONDO H, SAITOH Y, IMAMURA H, AND HIROHASHI S. c-MET expression in myofibroblasts. Role in autocrine activation and prognostic significance in lung adenocarcinoma. Am J Pathol 158: 1451-1463, 2001.
405. TOMASETTO C, MASSON R, LINARES JL, WENDLING C, LEFEBVRE O, CHENARD MP, AND RIO MC. pS2/TFF1 interacts directly with the VWFC cysteine-rich domains of mucins. Gastroenterology 118: 70-80, 2000.
406. TOMLINSON K, VAN BOKHOVEN A, VAN LEENDERS GJLH, RUIJTER ETG, JANSEN CFJ, BUSSEMAKERS MJG, AND SCHALKEN JA. Cadherin switching in human prostate cancer progression. Cancer Res 60: 3650-3654, 2000.
407. TOMLINSON JS, ALPAUGH ML, AND BARSKY SH. An intact overexpressed E-cadherin/α,β-catenin axis characterizes the lymphovascular emboli of inflammatory breast carcinoma. Cancer Res 61: 5231-5241, 2001.
408. TORBAN E AND GOODYER PR. Effects of PAX2 expression in a human fetal kidney (HEK293) cell line. Biochim Biophys Acta 1401: 53-62, 1998.
409. TRAN NL, NAGLE RB, CRESS AE, AND HEIMARK RL. N-cadherin expression in human prostate carcinoma cell lines. AN epithelial-mesenchymal transformation mediating adhesion with stromal cells. Am J Pathol 155: 787-798, 1999.
410. TRELSTAD RL, HAY ED, AND REVEL JD. Cell contact during early morphogenesis in the chick embryo. Dev Biol 16: 78-106, 1967.
411. TRUSOLINO L, BERTOTTI A, AND COMOGLIO PM. A signaling adapter function for alpha6beta4 integrin in the control of HGF-dependent invasive growth. Cell 107: 643-654, 2001.
412. TRUSOLINO L, CAVASSA S, ANGELINI P, ANDÒ M, BERTOTTI A, COMOGLIO PM, AND BOCCACCIO C. HGF/scatter factor selectively promotes cell invasion by increasing integrin avidity. FASEB J 14: 1629-1640, 2000.
413. TSELEPIS C, CHIDGEY M, NORTH A, AND GARROD D. Desmosomal adhesion inhibits invasive behavior. Proc Natl Acad Sci USA 95: 8064-8069, 1998.
414. TSUBAKIMOTO K, MATSUMOTO K, ABE H, ISHII J, AMANO M, KAIBUCHI K, AND ENDO T. Small GTPase RhoD suppresses cell migration and cytokinesis. Oncogene 18: 2431-2440, 1999.
415. UCHIDA N, SHIMAMURA K, MIYATANI S, COPELAND NG, GILBERT DJ, JENKINS NA, AND TAKEICHI M. Mouse aN-catenin: two isoforms, specific expression in the nervous system, and chromosomal localization of the gene. Dev Biol 163: 75-85, 1994.
416. VAKAET L, VANDEKERCHKOVE D, AND MAREEL M. Association de cellules HeLa avec de l'épithélium tubaire humain adulte. C R Soc Biol 165: 2225-2226, 1971.
417. VALLANCE BA AND FINLAY BB. Exploitation of host cells by enteropathogenic Escherichia coli. Proc Natl Acad Sci USA 97: 8799-8806, 2000.
418. VALLOROSI CJ, DAY KC, ZHAO X, RASHID MG, RUBIN MA, JOHNSON KR, WHEELOCK MJ, AND DAY ML. Truncation of the β-catenin binding domain of E-cadherin precedes epithelial apoptosis during prostate and mammary involution. J Biol Chem 275: 3328-3334, 2000.
419. VAN AKEN E, DE WEVER O, CORREIA DA ROCHA AS, AND MAREEL M. Defective E-cadherin/catenin complexes in human cancer. Virchows Arch 439: 725-751, 2001.
420. VAN AKEN EH, PAPELEU P, DE POTTER P, BRUYNEEL E, PHILIPPÉ J, SEREGARD S, KVANTA A, DE LAEY JJ, AND MAREEL MM. Structure and function of the N-cadherin/catenin complex in retinoblastoma. Invest Ophthalmol Vis Sci 43: 595-602, 2002.
421. VAN AKEN J, CUVELIER CA, DE WEVER N, GAO Y, MAREEL MM, AND ROELS HJ. Immunohistochemical analysis of E-cadherin expression in human colorectal tumours. Pathol Res Pract 189: 975-978, 1993.
422. VAN DEN BERG A, VISSER L, AND POPPEMA S. High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltrate in Hodgkin's lymphoma. Am J Pathol 154: 1685-1691, 1999.
423. VAN HENGEL J, GOHON L, BRUYNEEL E, VERMEULEN S, CORNELISSEN M, MAREEL M, AND VAN ROY F. Protein kinase C activation upregulates intercellular adhesion of a-catenin-negative human colon cancer cell variants via induction of desmosomes. J Cell Biol 137: 1103-1116, 1997.
424. ctn Armadillo-like catenin is counteracted by a nuclear export signal and by E-cadherin expression. Proc Natl Acad Sci USA 96: 7980-7985, 1999.
425. VAN HOORDE L, BRAET K, AND MAREEL M. The N-cadherin/catenin complex in colon fibroblasts and myofibroblasts. Cell Adhesion Commun 7: 139-150, 1999.
426. VAN HOORDE L, POCARD M, MARYNS I, POUPON MF, AND MAREEL M. Induction of invasion in vivo of α-catenin-positive HCT-8 human colon-cancer cells. Int J Cancer 88: 751-758, 2000.
427. VAN HOORDE L, VAN AKEN E, AND MAREEL M. Collagen type I: a substrate and a signal for invasion. In: Progress in Molecular and Subcellular Biology. Signaling Through the Matrix, edited by Macieira-Coelho A. Berlin: Springer-Verlag, 2000, vol. 25, p. 105-134.
428. VARNER JA AND CHERESH DA. Integrins and cancer. Curr Opin Cell Biol 8: 724-730, 1996.
429. VERMEULEN SI, BRUYNEEL EA, BRACKE ME, DE BRUYNE GK, VENNEKENS KM, VLEMINCKX KL, BERX GJ, VAN ROY FM, AND MAREEL MM. Transition from the noninvasive to the invasive phenotype and loss of a-catenin in human colon cancer cells. Cancer Res 55: 4722-4728, 1995.
430. VERMEULEN SJ, CHEN TR, SPELEMAN F, NOLLET F, VAN ROY FM, AND MAREEL MM. Did the four human cancer cell lines DLD-1, HCT-15, HCT-8, and HRT-18 originate from one and the same patient? Cancer Genet Cytogenet 107: 76-79, 1998.
431. VERMEULEN SJ, DEBRUYNE PR, MARRA G, SPELEMAN FP, BOUKAMP P, JIRICNY J, CUTHBERT AP, NEWBOLD RF, NOLLET FH, VAN ROY FM, AND MAREEL MM. hMSH6 deficiency and inactivation of the αE-catenin invasion-suppressor gene in HCT-8 colon cancer cells. Clin Exp Metastasis 17: 663-668, 1999.
432. VLEMINCKX K, VAKAET L JR, MAREEL M, FIERS W, AND VAN ROY F. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 66: 107-119, 1991.
433. VLEMINCKX KL, DEMAN JJ, BRUYNEEL EA, VANDENBOSSCHE GMR, KEIRSEBILCK AA, MAREEL MM, AND VAN ROY FM. Enlarged cell-associated proteoglycans abolish E-cadherin functionality in invasive tumor cells. Cancer Res 54: 873-877, 1994.
434. VLODAVSKY I, FRIEDMANN Y, ELKIN M, AINGORN H, ATZMON R, ISHAIMICHAELI R, BITAN M, PAPPO O, PERETZ T, MICHAL I, SPECTOR L, AND PECKER I. Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis. Nature Med 5: 793-802, 1999.
435. Vos CBJ, CLETON-JANSEN AM, BERX G, DE LEEUW WJF, TER HAAR NT, VAN ROY F, CORNELISSE CJ, PETERSE JL, AND VAN DE VIJVER MJ. E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis. Br J Cancer 76: 1131-1133, 1997.
436. WALTHER HE. Krebsmetastasen. Basel: Benno Schwabe, 1948.
437. WANG H, CHEN J, HOLLISTER K, SOWERS LC, AND FORMAN BM. Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. Mol Cell 3: 543-553, 1999.
438. 1 integrin avidity by CC chemokines in monocytes: implications for transendothelial chemotaxis. J Cell Biol 134: 1063-1073, 1996.
439. WEEKS BH, HE W, OLSON KL, AND WANG XJ. Inducible expression of transforming growth factor β1 in papillomas causes rapid metastasis. Cancer Res 61: 7435-7443, 2001.
440. WEIDNER KM, ARAKAKI N, HARTMANN G, VANDEKERCKHOVE J, WEINGART S, RIEDER H, FONATSCH C, TSUBOUCHI H, HISHIDA T, DAIKUHARA Y, AND BIRCHMEIER W. Evidence for the identity of human scatter factor and human hepatocyte growth factor. Proc Natl Acad Sci USA 88: 7001-7005, 1991.
441. WEIDNER KM, BEHRENS J, VANDEKERCKHOVE J, AND BIRCHMEIER W. Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells. J Cell Biol 111: 2097-2108, 1990.
442. WEIDNER KM, SACHS M, AND BIRCHMEIER W. The Met receptor tyrosine kinase transduces motility, proliferation, and morphogenic signals of scatter factor/hepatocyte growth factor in epithelial cells. J Cell Biol 121: 145-154, 1993.
443. WERB Z. ECM and cell surface proteolysis: regulating cellular ecology. Cell 91: 439-442, 1997.
444. WHANG YE, WU X, SUZUKI H, REITER RE, TRAN C, VESSELLA RL, SAID JW, ISAACS WB, AND SAWYERS CL. Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression. Proc Natl Acad Sci USA 95: 5246-5250, 1998.
445. WILLEMS I, BRUYNEEL E, NOË V, SLEGERS H, ZWIJSEN A, MÈGE RM, AND MAREEL M. Cadherin-dependent cell aggregation is affected by decapeptide derived from rat extracellular super-oxide dismutase. FEBS Lett 363: 289-292, 1995.
446. WILLERT K AND NUSSE R. β-Catenin: a key mediator of Wnt signaling. Curr Opin Genet Dev 8: 95-102, 1998.
447. WOJTUKIEWICZ MZ, TANG DG, BEN-JOSEF E, RENAUD C, WALZ DA, AND HONN KV. Solid tumor cells express functional "tethered ligand" thrombin receptor. Cancer Res 55: 698-704, 1995.
448. WOLFF E AND SCHNEIDER N. La transplantation prolongée d'un sarcome de souris sur des organes embryonnaires de poulet cultivés in vitro. C R S Soc Biol (Paris) 151: 1291-1292, 1957.
449. WONG WM, POULSOM R, AND WRIGHT NA. Trefoil peptides. Gut 44: 890-895, 1999.
450. WRANA JL. Regulation of Smad activity. Cell 100: 189-192, 2000.
451. Wu C, KEIGHTLEY SY, LEUNG-HAGESTEIJN C, RADEVA G, COPPOLINO M, GOICOECHEA S, MCDONALD JA, AND DEDHAR S. Integrin-linked protein kinase regulates fibronectin matrix assembly, E-cadherin expression, and tumorigenicity. J Biol Chem 273: 528-536, 1998.
452. XIE W, RADOMINSKA-PANDYA A, SHI Y, SIMON CM, NELSON MC, ONG ES, WAXMAN DJ, AND EVANS RM. An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids. Proc Natl Acad Sci USA 98: 3375-3380, 2001.
453. YAMADA T, TAKAOKA AS, NAISHIRO Y, HAYASHI R, MARUYAMA K, MAESAWA C, OCHIAI A, AND HIROHASHI S. Transactivation of the multidrug resistance I gene by T-cell factor 4/β-catenin complex in early colorectal carcinogenesis. Cancer Res 60: 4761-4766, 2000.
454. YAMADA Y, YOSHIMI N, HIROSE Y, MATSUNAGA K, KATAYAMA M, SAKATA K, SHIMIZU M, KUNO T, AND MORI H. Sequential analysis of morphological and biological properties of β-catenin-accumulated crypts, provable premalignant lesions independent of aberrant crypt foci in rat colon carcinogenesis. Cancer Res 61: 1874-1878, 2001.
455. YANG Y, SPITZER E, MEYER D, SACHS M, NIEMANN C, HARTMANN G, WEIDNER KM, BIRCHMEIER C, AND BIRCHMEIER W. Sequential requirement of hepatocyte growth factor and neuregulin in the morphogenesis and differentiation of the mammary gland. J Cell Biol 131: 215-226, 1995.
456. ZAJCHOWSKI DA, BARTHOLDI MF, GONG Y, WEBSTER L, LIU HL, MUNISHKIN A, BEAUHEIM C, HARVEY S, ETHIER SP, AND JOHNSON PH. Identification of gene expression profiles that predict the aggressive behavior of breast cancer cells. Cancer Res 61: 5168-5178, 2001.
457. ZHU W, LEBER B, AND ANDREWS DW. Cytoplasmic O-glycosylation prevents cell surface transport of E-cadherin during apoptosis. EMBO J 20: 5999-6007, 2001.
458. ZHURINSKY J, SHTUTMAN M, AND BEN-ZE'EV A. Plakoglobin and β-catenin: protein interactions, regulation and biological roles. J Cell Sci 113: 3127-3139, 2000.
459. ctn. J Biol Chem 275: 11264-11269, 2000.